<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8" /><meta http-equiv="Content-Language" content="en" /><title>Verbatim report of proceedings - Discharge 2014: European Medicines Agency (EMA) (A8-0114/2016 - Derek Vaughan) - Thursday, 28 April 2016</title><meta name="title" content="Verbatim report of proceedings - Discharge 2014: European Medicines Agency (EMA) (A8-0114/2016 - Derek Vaughan) - Thursday, 28 April 2016" /><meta name="language" content="en" /><meta name="robots" content="index, follow, noodp, noydir, notranslate" /><meta name="copyright" content="© European Union, 2016 - Source: European Parliament" /><meta name="available" content="28-04-2016" /><meta name="sipade-leg" content="8" /><meta name="sipade-type" content="CRE" /><meta property="og:title" content="Verbatim report of proceedings - Discharge 2014: European Medicines Agency (EMA) (A8-0114/2016 - Derek Vaughan) - Thursday, 28 April 2016" /><meta property="og:image" content="https://www.europarl.europa.eu/website/common/img/icon/sharelogo_facebook.jpg" /><link rel="canonical" href="https://www.europarl.europa.eu/doceo/document/CRE-8-2016-04-28-ITM-005-40_EN.html" /><link href="/doceo/data/css/style_common.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_common_print.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_sipade.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_activities.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/common_sides.css" type="text/css" rel="stylesheet" /><link href="/doceo/data/css/style_sipade_oj_sched.css" type="text/css" rel="stylesheet" />
<script src="/doceo/data/js/overlib.js" type="text/javascript"> </script>
<script src="/doceo/data/js/swap_images.js" type="text/javascript"> </script>
<script src="/doceo/data/js/sipade.js" type="text/javascript"> </script>
<script src="/doceo/data/js/jquery-1.4.4.js" type="text/javascript"> </script>
<script src="/doceo/data/js/sipade-OJ-SYN.js" type="text/javascript"> </script><!--ATI analytics script--><script type="text/javascript" data-tracker-name="ATInternet" defer data-value="/website/webanalytics/ati-doceo.js" src="//www.europarl.europa.eu/website/privacy-policy/privacy-policy.js" ></script></head><body bgcolor="#FFFFFF"><div id="overDiv" style="position:absolute; visibility:hidden; z-index:1000;"> </div><a name="top"></a><table cellpadding="0" cellspacing="0" border="0" width="100%"><tr><td><div id="header_sides" class="new">
<a href="/portal/en"><img alt="Go back to the Europarl portal" title="Go back to the Europarl portal" src="/doceo/data/img/EP_logo_neg_EN.png" /></a><h3 class="ep_hidden">Choisissez la langue de votre document :</h3><ul class="language_select">
            <li><a title="bg - български" class="bg on" href="/doceo/document/CRE-8-2016-04-28-ITM-005-40_BG.html">bg - български</a></li>
            <li><a title="es - español" class="es on" href="/doceo/document/CRE-8-2016-04-28-ITM-005-40_ES.html">es - español</a></li>
            <li><a title="cs - čeština" class="cs on" href="/doceo/document/CRE-8-2016-04-28-ITM-005-40_CS.html">cs - čeština</a></li>
            <li><a title="da - dansk" class="da on" href="/doceo/document/CRE-8-2016-04-28-ITM-005-40_DA.html">da - dansk</a></li>
            <li><a title="de - Deutsch" class="de on" href="/doceo/document/CRE-8-2016-04-28-ITM-005-40_DE.html">de - Deutsch</a></li>
            <li><a title="et - eesti keel" class="et on" href="/doceo/document/CRE-8-2016-04-28-ITM-005-40_ET.html">et - eesti keel</a></li>
            <li><a title="el - ελληνικά" class="el on" href="/doceo/document/CRE-8-2016-04-28-ITM-005-40_EL.html">el - ελληνικά</a></li>
            <li class="en selected" title="en - English">en - English<span> (Selected)</span></li>
            <li><a title="fr - français" class="fr on" href="/doceo/document/CRE-8-2016-04-28-ITM-005-40_FR.html">fr - français</a></li>
            <li class="ga" title="ga - Gaeilge">ga - Gaeilge</li>
            <li><a title="hr - hrvatski" class="hr on" href="/doceo/document/CRE-8-2016-04-28-ITM-005-40_HR.html">hr - hrvatski</a></li>
            <li><a title="it - italiano" class="it on" href="/doceo/document/CRE-8-2016-04-28-ITM-005-40_IT.html">it - italiano</a></li>
            <li><a title="lv - latviešu valoda" class="lv on" href="/doceo/document/CRE-8-2016-04-28-ITM-005-40_LV.html">lv - latviešu valoda</a></li>
            <li><a title="lt - lietuvių kalba" class="lt on" href="/doceo/document/CRE-8-2016-04-28-ITM-005-40_LT.html">lt - lietuvių kalba</a></li>
            <li><a title="hu - magyar" class="hu on" href="/doceo/document/CRE-8-2016-04-28-ITM-005-40_HU.html">hu - magyar</a></li>
            <li><a title="mt - Malti" class="mt on" href="/doceo/document/CRE-8-2016-04-28-ITM-005-40_MT.html">mt - Malti</a></li>
            <li><a title="nl - Nederlands" class="nl on" href="/doceo/document/CRE-8-2016-04-28-ITM-005-40_NL.html">nl - Nederlands</a></li>
            <li><a title="pl - polski" class="pl on" href="/doceo/document/CRE-8-2016-04-28-ITM-005-40_PL.html">pl - polski</a></li>
            <li><a title="pt - português" class="pt on" href="/doceo/document/CRE-8-2016-04-28-ITM-005-40_PT.html">pt - português</a></li>
            <li><a title="ro - română" class="ro on" href="/doceo/document/CRE-8-2016-04-28-ITM-005-40_RO.html">ro - română</a></li>
            <li><a title="sk - slovenčina" class="sk on" href="/doceo/document/CRE-8-2016-04-28-ITM-005-40_SK.html">sk - slovenčina</a></li>
            <li><a title="sl - slovenščina" class="sl on" href="/doceo/document/CRE-8-2016-04-28-ITM-005-40_SL.html">sl - slovenščina</a></li>
            <li><a title="fi - suomi" class="fi on" href="/doceo/document/CRE-8-2016-04-28-ITM-005-40_FI.html">fi - suomi</a></li>
            <li><a title="sv - svenska" class="sv on" href="/doceo/document/CRE-8-2016-04-28-ITM-005-40_SV.html">sv - svenska</a></li>
        </ul></div></td></tr><tr><td style="padding:10px;"><table width="100%" border="0" cellspacing="0" cellpadding="0"><tr><td><table border="0" align="left" cellpadding="0" cellspacing="0"><tr><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-8-2016-04-28-TOC_EN.html"><img src="/doceo/data/img/navi_index.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-8-2016-04-28-TOC_EN.html" title="Index">Index</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-8-2016-04-28-ITM-005-39_EN.html"><img src="/doceo/data/img/navi_previous.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-8-2016-04-28-ITM-005-39_EN.html" title="Previous">Previous</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td valign="middle"> <a href="/doceo/document/CRE-8-2016-04-28-ITM-005-41_EN.html" title="Next">Next</a> </td><td><a href="/doceo/document/CRE-8-2016-04-28-ITM-005-41_EN.html"><img src="/doceo/data/img/navi_next.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-8-2016-04-28_EN.html"><img src="/doceo/data/img/navi_moredetails.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-8-2016-04-28_EN.html" title="Full text">Full text</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td></tr><tr><td><img src="/doceo/data/img/spacer.gif" width="10" height="15" alt="" /></td></tr></table></td></tr></table>
                <table border="0" cellpadding="0" cellspacing="0" width="100%"><tbody><tr><td align="left"><span class="contents">Procedure : </span><a class="ring_ref_link" href="https://oeil.secure.europarl.europa.eu/oeil/popups/ficheprocedure.do?lang=en&amp;reference=2015/2171(DEC)">2015/2171(DEC)</a></td><td align="right"><table align="right" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td><img src="/doceo/data/img/ring_tabs_left_doc_unselected.gif" height="19" width="4" alt="" /></td><td class="Tabs_doc_unselected"><img src="/doceo/data/img/ring_navi.gif" width="17" height="14" alt="" />Document stages in plenary</td><td valign="middle"><img src="/doceo/data/img/ring_tabs_right_doc_unselected.gif" height="19" width="4" alt="" /></td></tr></tbody></table></td></tr></tbody></table><table class="doc_box_header" border="0" cellpadding="0" cellspacing="0" width="100%"><tbody><tr><td class="ring_multiple_bg" valign="top" colspan="7">Document selected :
            <span class="ring_ref_selected_header">A8-0114/2016</span></td></tr><tr><td width="25%" valign="top" class="ring_step_bg1" nowrap="nowrap"><p class="ring_step_title">Texts tabled :</p>
                        <a href="/doceo/document/A-8-2016-0114_EN.html" class="ring_ref_link">A8-0114/2016</a><br />
                    </td><td width="15" style="background-image:url(/doceo/data/img/ring_bg1.gif)"><img src="/doceo/data/img/ring_flech1.gif" height="22" width="13" border="0" alt="" /></td><td class="ring_step_bg2" valign="top" width="25%" nowrap="nowrap"><p class="ring_step_title">Debates :</p>
                        <a href="/doceo/document/PV-8-2016-04-27-ITM-017_EN.html" class="ring_ref_link">PV 27/04/2016 - 17</a><br />
                        <a href="/doceo/document/CRE-8-2016-04-27-ITM-017_EN.html" class="ring_ref_link">CRE 27/04/2016 - 17</a><br />
                    </td><td width="15" style="background-image:url(/doceo/data/img/ring_bg2.gif)"><img src="/doceo/data/img/ring_flech2.gif" width="13" height="22" border="0" alt="" /></td><td class="ring_step_bg3" valign="top" width="25%" nowrap="nowrap"><p class="ring_step_title">Votes :</p>
                        <a href="/doceo/document/PV-8-2016-04-28-ITM-004-40_EN.html" class="ring_ref_link">PV 28/04/2016 - 4.40</a><br />
                        <a class="ring_ref_selected">Explanations of votes</a><br />
                    </td><td width="19" style="background-image:url(/doceo/data/img/ring_bg3.gif)"><img src="/doceo/data/img/ring_flech3.gif" height="22" width="13" border="0" alt="" /></td><td class="ring_step_bg4" valign="top" width="25%" nowrap="nowrap"><p class="ring_step_title">Texts adopted :</p>
                        <a href="/doceo/document/TA-8-2016-0176_EN.html" class="ring_ref_link">P8_TA(2016)0176</a><br />
                    </td></tr></tbody></table><br />
            <table width="100%" border="0" cellpadding="5" cellspacing="0" class="doc_box_header">
<tr>
<td align="left" valign="top" style="background-image:url(/doceo/data/img/gradient_blue.gif)" class="title_TA">Verbatim report of proceedings</td><td valign="top" align="right" style="background-image:url(/doceo/data/img/gradient_blue.gif)"></td>
</tr>
<tr>
<td class="doc_title" align="left" valign="top" bgcolor="#F5F5F5">Thursday, 28 April 2016 - Brussels</td>
<td class="doc_title" align="right" valign="top" bgcolor="#F5F5F5">Revised edition</td></tr></table><br />
<table width="100%" border="0" cellpadding="0" cellspacing="0" class="doc_box_header" style="padding-bottom:5px"><tr valign="top"><td>
<table width="100%" border="0" cellpadding="5" cellspacing="0"><tr valign="top" style="padding-bottom:0px;padding-left:5px;padding-right:5px;padding-top:5px"><td align="left" style="background-image:url(/doceo/data/img/gradient_blue.gif)" class="doc_title"><img src="/doceo/data/img/arrow_title_doc.gif" width="8" height="14" border="0" align="absmiddle" alt="" /> 5.40. Discharge 2014: European Medicines Agency (EMA) (<a href="/doceo/document/A-8-2016-0114_EN.html">A8-0114/2016</a> - Derek Vaughan)</td></tr></table>
<a name="2-1389-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><span class="bold">Schriftliche Stimmerklärungen</span></p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1389-0187"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124831.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Isabella Adinolfi (EFDD), </span></span>  <span class="italic">per iscritto. ‒ </span>Attraverso l’adozione della decisione di discarico, il Parlamento conclude ciascun ciclo di bilancio, esercitando un controllo sulle spese effettuate dalle altre istituzioni europee. Generalmente, avendo riguardo alla relazione annuale della Corte dei conti, una decisione positiva è giustificata da un'esecuzione del bilancio priva di sprechi o inefficienze. Per quanto riguarda l'Agenzia europea per i medicinali (EMA), ho espresso voto negativo al discarico poiché sono rilevabili sprechi e inefficienze.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1389-0218"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125048.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Marina Albiol Guzmán (GUE/NGL), </span></span>  <span class="italic">por escrito. ‒ </span>He votado en contra de la presente descarga presupuestaria en favor de la Agencia Europea de Medicamentos porque, pese a cumplir con los requerimientos formales y procedimentales, esta Autoridad es la encargada de defender los intereses de la industria farmacéutica europea que mantiene fuertes bloqueos en el acceso a los medicamentos genéricos. Me he abstenido en la resolución porque aprueba los aspectos formales de la gestión de la Autoridad y señala algunas fallas de su funcionamiento durante el ejercicio de 2014. Pero hemos votado en contra de la descarga financiera porque la dirección política de esta Agencia en 2014, ha sido el boqueo sistemático en el acceso a nuevos medicamentos genéricos que hubieran permitido garantizar el acceso a numerosos tratamientos a los ciudadanos europeos.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1389-0226"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/113959.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Martina Anderson (GUE/NGL),</span></span>   <span class="italic">in writing</span><span class="bold">. </span>– I voted in favour of the granting of this discharge which was concerned with the European Medicines Agency (EMA).</p>
<p class="contents">There were no special irregularities which would justify a postponement.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1389-0234"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125110.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Νίκος Ανδρουλάκης (</span></span>  <span class="bold">S</span><span class="bold">&amp;</span><span class="bold">D</span><span class="bold">), </span><span class="italic">γραπτώς. ‒ </span>Υπερψήφισα την έκθεση σχετικά με την απαλλαγή όσον αφορά την εκτέλεση του προϋπολογισμού του Ευρωπαϊκού Οργανισμού Φαρμάκων για το οικονομικό έτος 2014, διότι αποτελεί αναπόσπαστο κομμάτι της προσπάθειας της Ευρωπαϊκής Ένωσης για επιτυχία στόχων και αποτελεσμάτων σε επίπεδο ευρωπαϊκών πολιτικών. Επιπρόσθετα, διαθέτει ένα ισχυρό δίκτυο και η εργασία του σε διάφορους τομείς αποτελεί ξεκάθαρο πλεονέκτημα για όλους τους ευρωπαίους πολίτες.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1389-0250"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124748.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Marie-Christine Arnautu (ENF), </span></span>  <span class="italic">par écrit. ‒ </span>J'ai voté contre cette décharge. Le rapport est manifestement trop conciliant malgré les problèmes constatés et fait fi des problèmes de conflits d'intérêts.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1389-0375"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124958.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Jonathan Arnott (EFDD), </span></span>  <span class="italic">in writing. ‒ </span>I voted against discharge on the grounds that I disapprove of the European Union, and consequently I disapprove of the expenditure in this area.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1389-0437"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124773.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Jean Arthuis (ALDE), </span></span>  <span class="italic">par écrit. ‒ </span>J'ai voté en faveur de cette résolution car cette agence de l'Union européenne a fait un grand pas en avant. Elle respecte les recommandations des années précédentes en matière de gestion financière: elle partage désormais certains de ses services avec d'autres agences de l'Union européenne, ce qui permet de faire des économies d'échelle. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1389-0500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96680.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Zigmantas Balčytis (S&amp;D), </span></span>  <span class="italic">raštu. ‒ </span>Balsavau už 2014 m. biudžeto įvykdymo ataskaitos patvirtinimą Europos vaistų agentūrai. Audito Rūmai savo ataskaitoje pareiškė, jog jiems pateiktas pagrįstas patikinimas, kad Agentūros 2014 finansinių metų metinės finansinės ataskaitos yra patikimos ir kad jose atspindimos operacijos yra teisėtos ir tvarkingos. Agentūros mokesčių reglamente yra pateikti galutiniai terminai, iki kurių turi būti surinkti mokesčiai iš pareiškėjų ir iki kada Agentūra turi atlikti atitinkamus mokėjimus nacionalinėms kompetentingoms institucijoms. Deja, daugumos Audito Rūmų tikrintų operacijų atveju šių galutinių terminų buvo nesilaikyta, todėl sutinku su Audito Rūmų raginimu, jog Agentūra privalo imtis visų reikiamų tolesnių veiksmų, siekiant užtikrinti visapusišką farmakologinio budrumo prievolių vykdymą ir veiksmingai informuotų biudžeto įvykdymą tvirtinančią instituciją apie priemones, kurių imtasi siekiant ištaisyti padėtį. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96877.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Zoltán Balczó (NI), </span></span>  <span class="italic">írásban. ‒ </span>Az Európai Gyógyszerügynökség 2014-es pénzügyi évre szóló általános költségvetésének végrehajtására vonatkozó mentesítésről szóló határozattal kapcsolatban fontosnak tartom kiemelni, hogy a Számvevőszék jelentése rámutatott arra, hogy az ügynökség díjszabályzata határidőket állapít meg a kérelmezőktől származó díjak beszedésére és az ügynökség által az illetékes tagállami hatóságok számára történő kifizetésekre. A jelentés szerint az Ügynökség a Számvevőszék által vizsgált ügyletek többségében ezeket a határidőket nem tartotta be. Az elektronikus ügyintézést, ezeknek az eljárásoknak a további automatizálását az Ügynökség eredetileg 2015 végéig tervezte megvalósítani, amit nem sikerült teljesítenie. </p>
<p class="contents">Fontosnak tartom kiemelni, hogy az ügynökség tegyen meg minden további szükséges lépést annak biztosítása érdekében, hogy maradéktalanul eleget tudjon tenni farmakovigilanciai kötelezettségeinek, és az ezekre meghozott intézkedésekről számoljon be, mert az ügynökség 2014 márciusában az adaptív engedélyezésre vonatkozóan egy olyan kísérleti projektet indított el, amelyet sem a Parlament, sem a Tanács nem támogatott. A 2014-es pénzügyi év során az Ügynökség saját költségvetés-végrehajtási aránya elérte a 94,32%-ot, ami 2,44%-os csökkenésnek felelt meg. A kifizetési előirányzatok végrehajtási aránya 82,30% volt, ami pedig 3,98%-os csökkenésnek felelt meg. A fent vázolt hiányosságok miatt a szavazatommal a mentesítés megadását nem támogattam.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0125"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124760.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Nicolas Bay (ENF), </span></span>  <span class="italic">par écrit. ‒ </span>Seuls 12 % du budget de l'EMA (Agence européenne des médicaments), qui a un rôle de pharmacovigilance et délivre les autorisations de mise sur le marché de classes de médicaments spécifiques (anticancéreux, anti-VIH, médicaments issus du génie génétique comme les vaccins controversés contre le cancer du col de l'utérus, Gardasil et Cervarix...) proviennent de fonds alloués par l'UE, le reste étant constitué de subventions de l'industrie pharmaceutique qui demande les autorisation, ce qui constitue un lien de dépendance et obère gravement l'objectivité de l'agence. </p>
<p class="contents">Il faut aussi noter plusieurs points problématiques sur la gestion budgétaire (dont le non-respect des échéances pour appeler les paiements des laboratoires et régler les agences nationales) et un lourd conflit d'intérêts: un membre du CA de l'agence représentant des sociétés dont les produits dépendent de l'autorisation de l'agence; autant de défaillances qui ont motivé mon vote défavorable sur ce rapport. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0250"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125002.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Hugues Bayet (S&amp;D), </span></span>  <span class="italic">par écrit. ‒ </span>J'ai approuvé l'octroi de la décharge à l'Agence européenne pour les medicaments, conformément au rapport adopté en commission du contrôle budgétaire.</p>
<p class="contents">La Cour des comptes estime en effet avoir reçu l'assurance raisonnable que les comptes annuels de l'Office pour 2014 étaient fiables et que les opérations sous-jacentes étaient légales et régulières.</p>
<p class="contents">Les députés ont par ailleurs souligné que l'Agence a révisé sa politique de traitement des déclarations d'intérêts des membres du comité scientifique et des experts. Elle a défini les concepts d'intérêts directs et indirects et a ordonné à l'ensemble des experts de déclarer tout intérêt direct ou indirect dans leurs déclarations d'intérêts annuelles. Des restrictions sont appliquées aux experts en matière d'intérêts directs ou indirects en fonction de leurs domaines d'activités.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0312"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124867.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Brando Benifei (S&amp;D), </span></span>  <span class="italic">per iscritto. ‒ </span>La procedura di discarico del bilancio rappresenta un momento importante nella vita istituzionale dell'Unione europea. In questa occasione il Parlamento europeo, unica istituzione eletta a suffragio universale dai cittadini, decide su raccomandazione del Consiglio se garantire o meno l'approvazione definitiva dell'esecuzione del bilancio per un determinato esercizio finanziario. Si tratta di un passaggio fondamentale che è anche l'occasione per indirizzare specifiche raccomandazioni alle istituzioni e alle agenzie che compongono la struttura comunitaria. Seguendo le indicazioni della commissione per il controllo dei bilanci (CONT), oggi ho deciso di votare a favore della relazione Vaughan sul discarico del bilancio del 2014 per l'Agenzia europea per i medicinali.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0343"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/135490.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Xabier Benito Ziluaga (GUE/NGL), </span></span>  <span class="italic">por escrito. ‒ </span>Se ha votado a favor de la aprobación la gestión y del cierre de cuentas al no encontrarse irregularidades reseñables. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0375"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124771.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Dominique Bilde (ENF), </span></span>  <span class="italic">par écrit. ‒ </span>J'ai refusé de voter en faveur de l'octroi de la décharge budgétaire pour l'Agence européenne des médicaments (EMA). Si en effet la Cour des comptes a validé les comptes de l'EMA, quelques éléments dans le fonctionnement de l'Agence soulèvent des interrogations.</p>
<p class="contents">Tout d'abord il faut rappeler que seuls 12 % de son budget proviennent de l'UE, le reste provenant de l'industrie pharmaceutique, ce qui est déjà en soit contestable du point de vue de l'éthique et des risques de conflits d'intérêts.</p>
<p class="contents">Par ailleurs, certains statuts de l'agence ont conduit à des opérations douteuses, comme par exemple le fait que l'EMA a pu passer un contrat de consulting pour 15 millions d'euros, sans même que le conseil d'administration de l'agence en soit informé. On peut également citer d'autres éléments perturbants comme le non-respect des échéances pour appeler les paiements des laboratoires et régler les agences nationales, ou encore les insuffisances en matière de contrôle de gestion.</p>
<p class="contents">Ce genre de défaillances ne permettait donc pas que l'on puisse octroyer la décharge.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/97198.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Mara Bizzotto (ENF), </span></span>  <span class="italic">per iscritto. ‒ </span>Preso atto delle criticità presenti nella relazione sull'Agenzia europea per i medicinali, ho optato per un voto di astensione. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0625"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125044.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">José Blanco López (S&amp;D), </span></span>  <span class="italic">por escrito. ‒ </span>He dado mi apoyo a este informe por el que se aprueba la gestión del director ejecutivo de la Agencia Europea de Medicamentos en la ejecución del presupuesto de la Agencia para el ejercicio 2014 a la vista del informe del Tribunal de Cuentas, en que declara haber obtenido garantías razonables sobre la fiabilidad de las cuentas anuales de la Agencia para el ejercicio 2014 y la legalidad y la regularidad de las operaciones correspondientes y en el que observa que los esfuerzos de supervisión del presupuesto durante el ejercicio 2014 dieron lugar a un porcentaje de ejecución presupuestaria del 94,32%, una disminución del 2,44 % en comparación con el ejercicio anterior. Igualmente, constata que la Agencia aumentó la transparencia en cuanto a sus procedimientos de selección de personal haciendo público el estado de los procedimientos externos en curso y el estado de las listas de reserva en la página web externa de la Agencia, y que también mejoró la documentación relativa a estos procedimientos.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96681.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Vilija Blinkevičiūtė (S&amp;D), </span></span>  <span class="italic">raštu. ‒ </span>Balsavau dėl šio pranešimo, nes juo Parlamentas patvirtina Europos vaistų agentūros vykdomajam direktoriui, kad Agentūros 2014 finansinių metų biudžetas įvykdytas. Audito Rūmai savo ataskaitoje dėl Agentūros 2014 finansinių metų metinių finansinių ataskaitų pareiškė, jog jiems pateiktas pagrįstas patikinimas, kad Agentūros 2014 finansinių metų metinės finansinės ataskaitos yra patikimos ir kad jose atspindimos operacijos yra teisėtos ir tvarkingos. Vis dėlto, Parlamentas, remdamasis Audito Rūmų ataskaita pažymi, kad Agentūros mokesčių reglamente yra pateikti galutiniai terminai, iki kurių turi būti surinkti mokesčiai iš pareiškėjų ir Agentūra turi atlikti atitinkamus mokėjimus nacionalinėms kompetentingoms institucijoms. Pabrėžia, kad daugumos Audito Rūmų tikrintų operacijų atveju šių galutinių terminų nesilaikyta, tačiau, remdamasis Agentūros suteikta informacija, patikina, kad Agentūra pertvarkė ir racionalizavo savo pagrindinius veiklos procesus, įskaitant susijusius su finansiniais leidimais ir mokesčių rinkimu, bei atkreipia dėmesį į tai, kad Agentūra planavo iki 2015 m. pabaigos atlikti tolesnį šių procesų automatizavimą. Todėl Parlamentas ragina Agentūrą, kad ji imtųsi visų reikiamų tolesnių veiksmų siekdama užtikrinti visapusišką farmakologinio budrumo prievolių vykdymą ir veiksmingai informuotų biudžeto įvykdymą tvirtinančią instituciją apie priemones, kurių imtasi siekiant ištaisyti padėtį.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0812"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125004.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Franc Bogovič (PPE), </span></span>  <span class="italic">pisno. ‒ </span>Podprl sem predlog Evropskega parlamenta o razrešnici glede izvrševanja proračuna Evropske agencije za zdravila za proračunsko leto 2014.</p>
<p class="contents">Evropski parlament je ugotovil, da so podatki v končnem zaključnem računu Evropske agencije za zdravila takšni kot v prilogi k poročilu Računskega sodišča. Agencija je v letu 2014 ocenila učinkovitost svojega osrednjega sistema notranje kontrole, rezultati so pokazali, da so notranje kontrole agencije v tem letu delovale dobro, tako da agencija zaradi njih ni bila izpostavljena tveganju.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0827"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124984.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Lynn Boylan (GUE/NGL),</span></span>   <span class="italic">in writing</span><span class="bold">. </span>– I voted in favour of the granting of this discharge which was concerned with the European Medicines Agency (EMA)</p>
<p class="contents">There were no special irregularities which would justify a postponement.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0843"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/28346.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Mercedes Bresso (S&amp;D), </span></span>  <span class="italic">per iscritto. ‒ </span>Ho votato a favore de discarico di bilancio 2014 dell'Agenzia europea per i medicinali (EMA) perché ritengo che le sue finanze siano state gestite in maniera oculata e compatibile con le previsioni del bilancio per l'anno in questione.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0875"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124787.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Renata Briano (S&amp;D), </span></span>  <span class="italic">per iscritto. ‒ </span>La procedura di discarico è uno strumento fondamentale nelle mani del Parlamento europeo per vigilare sull'esecuzione del bilancio delle diverse istituzioni e agenzie europee ed effettuare così un controllo politico approfondito sull'impiego dei fondi pubblici.</p>
<p class="contents">Si tratta di una prassi consolidata, essenziale per garantire la trasparenza e la responsabilità democratica delle istituzioni nei confronti dei contribuenti dell'UE.</p>
<p class="contents">Affinché tale prerogativa sia esercitata pienamente, occorre tuttavia che l'insieme delle istituzioni europee collabori in maniera aperta e costruttiva con la commissione per il controllo dei bilanci del Parlamento europeo, fornendo tutte le informazioni e i documenti necessari, rispondendo alle interrogazioni scritte e partecipando alle audizioni e alle discussioni sull'esecuzione del bilancio previste. </p>
<p class="contents">In tal senso, se da un lato la maggior parte delle istituzioni dimostra un atteggiamento cooperativo facilitando il controllo del Parlamento sull'esecuzione del loro bilancio, alcune istituzioni non collaborano in maniera soddisfacente, violando i principi di leale cooperazione e di trasparenza sanciti dai trattati. Penso in particolare al Consiglio, il quale dal 2009 si rifiuta di sottoporsi all'esercizio di discarico, eludendo di fatto il controllo politico su oltre 3 miliardi di fondi pubblici europei spesi, alimentando così il sentimento di sfiducia nei confronti delle istituzioni europee.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0890"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124757.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Steeve Briois (ENF), </span></span>  <span class="italic">par écrit. ‒ </span>L'agence européenne du médicament délivre les autorisations de mise sur le marché de classes de médicaments spécifiques. 88 % de ses ressources financières sont issues de l'industrie pharmaceutique, plaçant l'agence dans un lien de dépendance à l'endroit de ceux à qui elle délivre les autorisations. Le non-respect des échéances pour appeler les paiements des laboratoires et régler les agences nationales, ainsi que le lourd conflit d'intérêts révélé par l'agence elle-même visant un membre du conseil d'administration, ont motivé mon choix de voter contre la décharge budgétaire. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0906"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124869.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Gianluca Buonanno (ENF), </span></span>  <span class="italic">per iscritto. ‒ </span>Si assiste a una diminuzione degli impegni di bilancio del 2,4% rispetto all’anno precedente ma, in generale, viene sottolineata la sostenibilità della situazione finanziaria. Da segnalare il fatto che nel marzo 2014 l'Agenzia ha avviato un progetto pilota sulle licenze adattive, che il Parlamento e il Consiglio non hanno sostenuto in quanto l'applicazione di percorsi adattivi trasferirebbe l'onere della prova dalla pre-commercializzazione alla post-commercializzazione, creando una situazione in cui le autorizzazioni all'immissione in commercio premature potrebbero diventare la norma. Sembra pertanto che, da un punto di vista di "indirizzo" generale, piuttosto che da quello squisitamente amministrativo, vi sia necessità di un maggiore presidio e controllo sull’attività dell'Agenzia. Voto di astensione.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0909"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124851.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Nicola Caputo (S&amp;D), </span></span>  <span class="italic">per iscritto. ‒ </span>Oggi ho votato a favore della posizione della commissione per il controllo dei bilanci che concede il discarico per l'esecuzione del bilancio dell'Agenzia europea per i medicinali per l'esercizio 2014 perché la Corte dei conti, nella sua relazione sui conti annuali dell'Agenzia relativi all'esercizio 2014, dichiara di aver ottenuto garanzie ragionevoli in merito all'affidabilità dei conti annuali dell'Agenzia per l'esercizio 2014. Tuttavia, prendo atto che, nonostante il regolamento sui diritti dell'Agenzia preveda date di scadenza per la riscossione dei diritti dai richiedenti e per i relativi pagamenti dell'Agenzia destinati alle autorità nazionali competenti, tali date non sono state rispettate nella maggior parte delle transazioni esaminate dalla Corte dei conti e invita l'Agenzia a rispettarle. E questo è dunque un aspetto da migliorare. Così come rilevo che la Corte dei conti ha evidenziato carenze significative nel controllo di gestione, con l'implicazione di considerevoli rischi operativi e finanziari per l'Agenzia. Dunque, accolgo positivamente l'istituzione di un piano d'azione per affrontare la questione e invito l'Agenzia a esaminare in modo approfondito l'efficacia delle misure adottate.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0910"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124986.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Matt Carthy (GUE/NGL), </span></span>  <span class="italic">in writing. ‒ </span>According to the Treaties, the Parliament has a right of scrutiny of the legality and regularity of the operating expenditure of the institutions and agencies every year. The main goal of the discharge procedure is to ensure that public funds are used in the best possible way. This vote concerns the discharge reports related to one of the EU's decentralised agencies, The European Medicines Agency. The overall conclusion in the Vaughan reports is that the supervisory and control systems required by the Financial Regulation and the transactions tested were free from material error of legality and regularity. For these reasons I voted in favour. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0911"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124971.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">James Carver (EFDD), </span></span>  <span class="italic">in writing. ‒ </span>UKIP voted against the discharge votes for multiple reasons. Primarily we are against the EU spending taxpayers’ money therefore we do not consent to this money being spent. Second of all, the lack of transparency in these procedures is of real concern to us. Finally many of these discharge reports call for a motion for resolution which requires further EU engagement which we are principally against.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0913"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/28122.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">David Casa (PPE), </span></span>  <span class="italic">in writing. ‒ </span>I voted in favour of this report which grants discharge to the European Medicines Agency for the year 2014. Its accounts and performance were more than satisfactory. Additionally, I welcome the fact that the Agency has improved and managed to implement the recommendations of the Internal Audit Service from the year 2013. I regret however that the Agency's budget implementation was rather low; especially that it was even lower than in the previous year. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0917"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125061.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Κώστας Χρυσόγονος (</span></span>  <span class="bold">GUE</span><span class="bold">/</span><span class="bold">NGL</span><span class="bold">), </span><span class="italic">γραπτώς. ‒ </span>Η έκθεση σχετικά με την απαλλαγή του Ευρωπαϊκού Οργανισμού Φαρμάκων ως προς την εκτέλεση του γενικού προϋπολογισμού της Ευρωπαϊκής Ένωσης για το οικονομικό έτος 2014 αποτελεί μια καθιερωμένη διαδικασία ως προς τις αποφάσεις που ελήφθησαν και τις κινήσεις που έγιναν σχετικά με τη διαχείριση του προϋπολογισμού. Καθώς δεν προέκυψαν ζητήματα ικανά να οδηγήσουν σε απόρριψη των χειρισμών που πραγματοποιήθηκαν, ψήφισα θετικά.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0919"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124772.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Alberto Cirio (PPE), </span></span>  <span class="italic">per iscritto. ‒ </span>Ho notato, analizzando questa relazione, come le risorse economiche disponibili a questo ufficio siano state utilizzate, prima di tutto, nella piena attenzione agli sprechi e, in secondo luogo, per ottimizzare al massimo l'operatività e l'efficienza del lavoro di tale agenzia. Essendomi quindi reso conto di come bene siano state amministrate le risorse attribuitegli, ho votato a favore.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0921"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124988.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Deirdre Clune (PPE), </span></span>  <span class="italic">in writing. ‒ </span>These are the annual discharge reports on the agencies following the presentation of the European Court of Auditors reports for the 2014 financial year. The number of decentralised agencies concerned by the discharge is 32. The European Court of Auditors gave an unqualified (positive) opinion to all agencies concerning the reliability of their accounts and the legality and regularity of the underlying transactions. </p>
<p class="contents">The Court of Auditors noted that overall there were less problems with agencies than in previous years and as such not as many comments were required in the Court's reports. Two agencies, EIT and EU-LISA have, however, been given an ‘emphasis of matter’ and were marked for follow up.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0925"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/1892.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Carlos Coelho (PPE), </span></span>  <span class="italic">por escrito. ‒ </span>A Agência Europeia de Medicamentos desempenha um papel essencial na proteção e promoção da saúde pública e da saúde dos animais, procedendo à avaliação e supervisão dos medicamentos para utilização humana e veterinária.</p>
<p class="contents">No seu relatório, o Tribunal de Contas refere que as operações relativas às contas anuais da agência referentes ao exercício de 2014 são fiáveis e que as operações subjacentes são legais e regulares. Por outro lado, o Tribunal de Contas assinala os esforços de acompanhamento do orçamento durante o exercício de 2014, contribuindo para a elevada taxa de execução orçamental de 94,32%, apesar de representar um decréscimo de 2,44% relativamente ao ano anterior.</p>
<p class="contents">Neste sentido, apoio o Relatório Vaughan que vem proceder à quitação pelo Parlamento Europeu do orçamento relativo Agência Europeia de Medicamentos para o exercício de 2014.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0927"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96775.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Lara Comi (PPE), </span></span>  <span class="italic">per iscritto. ‒ </span>Accolgo positivamente l'impegno dell'Agenzia europea per i medicinali per garantire maggiore trasparenza nella gestione finanziaria e del bilancio. Pertanto, ho deciso di esprimere il mio voto favorevole alla procedura di discarico per l'esecuzione di bilancio dell'EMA per l'esercizio del 2014.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0928"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124968.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Therese Comodini Cachia (PPE), </span></span>  <span class="italic">in writing. ‒ </span>Every effort is necessary to strengthen procedures and practices aimed at safeguarding the financial interests of the Union and to actively contribute to a results-oriented discharge process.</p>
<p class="contents">I share the concerned that, despite the identified weakness in the functioning of pharmacovigilance, the Agency launched in March 2014 a pilot project on adaptive licencing, that was endorsed neither by the Parliament nor by the Council, as implementing adaptive pathways would shift the burden of evidence from pre-marketing to post-marketing, leading to a situation where premature marketing authorisations could become the rule.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0001"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/40224.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Andi Cristea (S&amp;D), </span></span>  <span class="italic">în scris. ‒ </span>Având în vedere constatarea Curții de Conturi referitoare la legalitatea și corectitudinea, sub toate aspectele semnificative, ale tranzacțiilor subiacente conturilor anuale ale Agenției pentru exercițiul financiar 2014 și salutând dezvoltarea și adoptarea de către agenție a unei strategii anti-fraudă, în 2014, am acordat directorului executiv al Agenției Europene pentru Medicamente descărcarea de gestiune pentru execuția bugetului agenției aferent exercițiului financiar 2014.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0929"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124970.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Miriam Dalli (S&amp;D), </span></span>  <span class="italic">in writing. ‒ </span>I voted in favour of granting this discharge since I believe that the European Medicines Agency (EMA) is extremely important for the EU as a whole. I further believe that this Agency registered progress with the way it dealt with its expenditure, management of human resources and procurement procedures.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0931"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/35135.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Daniel Dalton (ECR), </span></span>  <span class="italic">in writing</span><span class="bold"><span class="italic">.</span></span><span class="italic"> ‒ </span>I voted to postpone discharge on this report today because the European Court of Auditors did not give the EU budget as a whole a positive statement of assurance. The level of error for the year 2014 was estimated to be 4.4%, which, whilst a slight improvement on 2013, is still too high. It is the job of the Parliament to verify that the EU budget was spent in accordance with the rules and in line with the principles of sound financial management, and unfortunately the Court of Auditors found that was not the case for the year 2014. </p>
<p class="contents">We need more simplification of key areas of financial management in the EU budget and a stronger focus on tackling parts of the budget with a higher risk of problems.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0933"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/97296.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Michel Dantin (PPE), </span></span>  <span class="italic">par écrit. ‒ </span>Le présent rapport propose d’accorder la décharge pour l’exercice budgétaire 2014 à l’Agence européenne des médicaments. En charge d'évaluer, coordonner et superviser le développement des nouveaux médicaments à usage humain et vétérinaire dans l’Union européenne, l’agence a reçu pour l’année 2013 une contribution de 282 474 000 EUR, soit une hausse de 12,29 % par rapport à 2013 (12,53 % du budget de l'Agence est issu du budget de l'Union). Elle dispose d’après la Cour des comptes européenne d’un taux d’exécution budgétaire satisfaisant à hauteur de 94,32 % en crédits d’engagement et de 82,30 % en crédit de paiement. Considérant que l'audit annuel de la Cour des comptes n'a relevé aucun problème notable dans l'exécution du budget, j’ai voté en faveur de la décharge.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1389-0125"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96958.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">William (The Earl of) Dartmouth (EFDD), </span></span>  <span class="italic">in writing. ‒ </span>UKIP voted against the discharge votes for multiple reasons. Primarily we are against the EU spending taxpayers’ money therefore we do not consent to this money being spent. Second of all, the lack of transparency in these procedures is of real concern to us. Finally many of these discharge reports call for a motion for resolution which requires further EU engagement which we are principally against.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0937"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124714.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Andor Deli (PPE), </span></span>  <span class="italic">írásban. ‒ </span>Az Európai Számvevőszék 2014-es pénzügyi évre vonatkozó éves jelentésének bemutatását követően a 2014. évi zárszámadási eljárás keretében az Európai Parlament Költségvetési Ellenőrző Bizottsága elvégezte az Európai Unió általános költségvetésének az Európai Gyógyszerügynökségre vonatkozó pénzügyi ellenőrzését. A Számvevőszék megállapította, hogy a vizsgálatok során kellő mértékben megbizonyosodott arról, hogy az Európai Gyógyszerügynökség 2014-es pénzügyi évre vonatkozó éves beszámolója megbízható, és hogy az annak alapjául szolgáló ügyletek jogszerűek és szabályszerűek voltak. A zárszámadási jelentés megállapítja, hogy a pénzügyi átvilágítás rendben lezajlott és a vizsgálat során nagyobb hiányosságokat nem tapasztaltak. A plenáris szavazáson a mentesítés megadását támogattam.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0915"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124812.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Fabio Massimo Castaldo (EFDD), </span></span>  <span class="italic">per iscritto. ‒ </span>Ho votato a favore della risoluzione in quanto mette in luce, in modo rigoroso e sistematico, le problematiche specifiche dell'EMA.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0924"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/26837.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Λευτέρης Χριστοφόρου (PPE), </span></span>  <span class="italic">γραπτώς. ‒ </span>Στηρίζουμε την έκθεση, η οποία δικαιολογημένα χορηγεί απαλλαγή στον εκτελεστικό διευθυντή του Ευρωπαϊκού Οργανισμού Φαρμάκων όσον αφορά την εκτέλεση του προϋπολογισμού του Οργανισμού για το οικονομικό έτος 2014.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0952"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96826.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Tamás Deutsch (PPE),</span></span>   <span class="italic">írásban</span><span class="bold">. –</span> Az Európai Számvevőszék 2014-es pénzügyi évre vonatkozó éves jelentésének bemutatását követően a 2014. évi zárszámadási eljárás keretében az Európai Parlament Költségvetési Ellenőrző Bizottsága elvégezte az Európai Unió általános költségvetésének az Európai Gyógyszerügynökségre vonatkozó pénzügyi ellenőrzését. A szakbizottság elsődleges feladata a közösségi költségvetés végrehajtásának szabályosságát és hatékonyságát biztosítani, ellenőrizni. A Számvevőszék megállapította, hogy a vizsgálatok során kellő mértékben megbizonyosodott arról, hogy az Európai Gyógyszerügynökség 2014-es pénzügyi évre vonatkozó éves beszámolója megbízható, és hogy az annak alapjául szolgáló ügyletek jogszerűek és szabályszerűek voltak. </p>
<p class="contents">A zárszámadási jelentés megállapítja, hogy a pénzügyi átvilágítás rendben lezajlott és a vizsgálat során nagyobb hiányosságokat nem tapasztaltak. A szakbizottság április eleji ülésén a mentesítés megadásáról, a 2014-es számlák lezárásáról döntött. A szakbizottsági szavazáson és a plenáris szavazáson is a mentesítés megadását támogattam.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0960"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124750.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Mireille D'Ornano (ENF), </span></span>  <span class="italic">par écrit. ‒ </span>L'Agence européenne du médicament délivre les autorisations de mise sur le marché des nombreux types de médicaments et supervise la pharmacovigilance à l'échelle européenne. Seuls 12 % de son budget, d'un total de 282 millions d'euros en 2014, sont issus de l'Union. Le reste provient de l'industrie pharmaceutique qui sollicite les autorisations, ce qui est problématique étant donné le lien de dépendance qui en découle et nuit à son objectivité. La Cour des comptes souligne le passage d'un contrat de consulting pour 15 millions d'euros sans en avoir informé le conseil d'administration, ce qui est regrettable. Elle pointe également le non-respect des échéances pour appeler les paiements des laboratoires et régler les agences nationales ou encore des insuffisances en matière de contrôle de gestion. Pour finir, le Professeur Nistico a représenté le Parlement durant trois mandats au Conseil d'administration, sans préciser qu'il occupait des fonctions éminentes pour une société anglaise et une société chinoise dont l'autorisation des produits dépend précisément de l'Agence. Dans ces conditions, j'ai voté contre cette décharge. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0964"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124873.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Ангел Джамбазки (ECR), </span></span>  <span class="italic">в писмена форма. ‒ </span>Гласувах против освобождаването от отговорност на Европейската агенция по лекарствата във връзка с изпълнението на общия бюджет на ЕС, защото моето виждане и виждането на моята група е свързано с отлагане на приемането на решението за освобождаване от отговорност, тъй като за нас е важно да видим кои европейски структури работят ефективно и не прахосват парите на европееца, както и да държим под контрол тези, които изразходват повече пари, но не вършат работа. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0968"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124711.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Norbert Erdős (PPE), </span></span>  <span class="italic">írásban. ‒ </span>Az Európai Számvevőszék 2014-es pénzügyi évre vonatkozó éves jelentésének bemutatását követően a 2014. évi zárszámadási eljárás keretében az Európai Parlament Költségvetési Ellenőrző Bizottsága elvégezte az Európai Unió általános költségvetésének az Európai Gyógyszerügynökségre vonatkozó pénzügyi ellenőrzését. A szakbizottság elsődleges feladata a közösségi költségvetés végrehajtásának szabályosságát és hatékonyságát biztosítani, ellenőrizni. A Számvevőszék megállapította, hogy a vizsgálatok során kellő mértékben megbizonyosodott arról, hogy az Európai Gyógyszerügynökség 2014-es pénzügyi évre vonatkozó éves beszámolója megbízható, és hogy az annak alapjául szolgáló ügyletek jogszerűek és szabályszerűek voltak. </p>
<p class="contents">A zárszámadási jelentés megállapítja, hogy a pénzügyi átvilágítás rendben lezajlott és a vizsgálat során nagyobb hiányosságokat nem tapasztaltak. A szakbizottság április eleji ülésén a mentesítés megadásáról, a 2014-es számlák lezárásáról döntött. A plenáris szavazáson a mentesítés megadását támogattam.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0984"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124767.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Edouard Ferrand (ENF), </span></span>  <span class="italic">par écrit. ‒ </span>Vote contre: la Cour des comptes souligne plusieurs points préoccupants: le passage d'un contrat de consulting pour 15M € sans informer le conseil d'administration (même si c'est conforme aux statuts de l'agence), le non-respect des échéances pour appeler les paiements des laboratoires et régler les agences nationales ou encore des insuffisances en matière de contrôle de gestion. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0992"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/4465.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Raffaele Fitto (ECR), </span></span>  <span class="italic">per iscritto. ‒ </span>Ho votato contro la concessione del discarico di bilancio per l'Agenzia europea per i medicinali. Vi sono diverse criticità e una rilevante percentuale di errore, riscontrate anche dalla Corte dei conti europea. Ritengo di fondamentale importanza impegnarsi su un terreno che renda le agenzie europee meno costose, meno distanti dalla gente e più vicine alle esigenze e agli interessi dei cittadini europei. Per questo motivo, è necessario un rinvio del discarico. In un periodo di forte euroscetticismo occorre un diverso tipo di approccio all'investimento del denaro pubblico, che non alimenti ulteriormente il sentimento di sfiducia dei cittadini europei nei confronti delle istituzioni europee e di ciò che rappresentano.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1390-0996"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124985.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Luke Ming Flanagan (GUE/NGL), </span></span>  <span class="italic">in writing. ‒ </span>The discharge report was favourable overall so I voted for.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1391-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/23868.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Monika Flašíková Beňová (S&amp;D), </span></span>  <span class="italic">písomne ‒ </span>Pri tomto konkrétnom hlasovaní ide o udelenie rozpočtového absolutória pre Európsku agentúru pre lieky.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1391-0500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125070.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Λάμπρος Φουντούλης (</span></span>  <span class="bold">NI</span><span class="bold">), </span><span class="italic">γραπτώς. ‒ </span>Καταψηφίζω την έκθεση σχετικά με την απαλλαγή όσον αφορά την εκτέλεση του προϋπολογισμού του Ευρωπαϊκού Οργανισμού Φαρμάκων για το οικονομικό έτος 2014, καθώς ο Ευρωπαϊκός Οργανισμός Φαρμάκων μπορεί εύκολα να χαρακτηριστεί ως ένας από τους ίσως πιο διεφθαρμένους οργανισμούς στην Ευρώπη. Το μεγαλύτερο μέρος της χρηματοδότησής του προέρχεται από τις ίδιες τις εταιρείες που υποτίθεται πως ελέγχει, ενώ και οι ενέργειές του μάλλον αποδεικνύουν πως λειτουργεί με γνώμονα το συμφέρον των εταιρειών αυτών. Χαρακτηριστικό παράδειγμα η πρόταση του για αδειοδότηση και διάθεση στην αγορά φαρμάκων πριν από την απόδειξη της καταλληλότητάς τους. Τέλος, δεν θα μπορούσα σε καμία περίπτωση να εγκρίνω την διάθεση δεκαπέντε εκατομμυρίων ευρώ σε υπηρεσίες συμβούλων.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1391-0750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124790.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Doru-Claudian Frunzulică (S&amp;D), </span></span>  <span class="italic">in writing. ‒ </span>I backed this report as agreed in Committee, granting discharge to EMA.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1392-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/28150.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Kinga Gál (PPE), </span></span>  <span class="italic">írásban. ‒ </span>Az Európai Számvevőszék 2014-es pénzügyi évre vonatkozó éves jelentésének bemutatását követően a 2014. évi zárszámadási eljárás keretében az Európai Parlament Költségvetési Ellenőrző Bizottsága elvégezte az Európai Unió általános költségvetésének az Európai Gyógyszerügynökségre vonatkozó pénzügyi ellenőrzését. A szakbizottság elsődleges feladata a közösségi költségvetés végrehajtásának szabályosságát és hatékonyságát biztosítani, ellenőrizni. A Számvevőszék megállapította, hogy a vizsgálatok során kellő mértékben megbizonyosodott arról, hogy az Európai Gyógyszerügynökség 2014-es pénzügyi évre vonatkozó éves beszámolója megbízható, és hogy az annak alapjául szolgáló ügyletek jogszerűek és szabályszerűek voltak. </p>
<p class="contents">A zárszámadási jelentés megállapítja, hogy a pénzügyi átvilágítás rendben lezajlott és a vizsgálat során nagyobb hiányosságokat nem tapasztaltak. A szakbizottság április eleji ülésén a mentesítés megadásáról, a 2014-es számlák lezárásáról döntött. A szakbizottsági szavazáson és a plenáris szavazáson is a mentesítés megadását támogattam.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/102886.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Ildikó Gáll-Pelcz (PPE), </span></span>  <span class="italic">írásban. ‒ </span>Az Európai Számvevőszék 2014-es pénzügyi évre vonatkozó éves jelentésének bemutatását követően a 2014. évi zárszámadási eljárás keretében az Európai Parlament Költségvetési Ellenőrző Bizottsága elvégezte az Európai Unió általános költségvetésének az Innovatív gyógyszerek kutatására irányuló kezdeményezést megvalósító közös vállalkozásra vonatkozó pénzügyi ellenőrzését. A Számvevőszék kijelentette, hogy kellő mértékben megbizonyosodott arról, hogy az intézet éves beszámolója megbízható, és a beszámolókban foglalt ügyleteket jogszerűnek és szabályszerűnek ítélte. </p>
<p class="contents">Az előző pénzügyi évhez képest jelentős előrelépést sikerült elérnie a közös vállalkozásnak és egy olyan cselekvési tervet sikerült véghezvinnie, amely világos és konkrét eredményeket hozott az összeférhetetlenségek megelőzése és az átláthatóság megerősítése vonatkozásában. A szakbizottság április eleji ülésén a mentesítés megadásáról döntött. A szakbizottsági szavazáson és a plenáris szavazáson is a mentesítés megadását támogattam.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0015"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124815.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Arne Gericke (ECR), </span></span>  <span class="italic">schriftlich. ‒ </span>Ich habe gegen die Entlastung 2014 der Europäischen Arzneimittel-Agentur gestimmt. Grundsätzlich begrüße ich die von der Agentur wahrgenommenen Aufgaben, meine aber, sie wären innerhalb der EU-Kommission besser zu erfüllen und benötigen nicht die aufwändigen, dezentralen Strukturen der europäischen "Agenturitis". </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0031"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124807.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Jens Gieseke (PPE), </span></span>  <span class="italic">schriftlich. ‒ </span>Die Bewertungen und Statistiken der EMA spielen in essentiellen Gesundheitsfragen eine wichtige Rolle. Sie bewertet die Risiken und die ordnungsgemäße Verwendung der Arzneimittel anhand von europäischen Standards. Als Mitglied des ENVI-Ausschusses halte ich sie für eine elementare Einrichtung, die uns bei der Ausschussarbeit beratend zur Seite steht.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0046"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124965.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Nathan Gill (EFDD), </span></span>  <span class="italic">in writing. ‒ </span>I voted against discharge on the grounds that I disapprove of the European Union, and consequently I disapprove of the expenditure in this area.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0054"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/21331.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Sylvie Goddyn (ENF), </span></span>  <span class="italic">par écrit. ‒ </span>L'Agence européenne du médicament délivre les autorisations de mise sur le marché de médicaments spécifiques (anticancéreux, anti-VIH, médicaments issus du génie génétique comme les vaccins controversés contre le cancer du col de l'utérus, Gardasil et Cervarix...). Elle est également en charge des médicaments appelés "biosimilaires", génériques produits par biotechnologie. Elle s'acquitte également de la pharmacovigilance à l'échelle européenne.</p>
<p class="contents">Dotée d'un budget 2014 de 282 M d’euros, elle emploie 580 personnes. Seuls 12 % de son budget sont issus de l'Union, le reste provient de l'industrie pharmaceutique, ce qui est déjà problématique en termes d'indépendance.</p>
<p class="contents">La Cour des comptes souligne plusieurs points préoccupants: par exemple, le non-respect des échéances pour appeler les paiements des laboratoires et régler les agences nationales ou encore des insuffisances en matière de contrôle de gestion. </p>
<p class="contents">On note aussi un lourd conflit d'intérêts. Le Professeur Nistico a représenté le Parlement durant trois mandats (9 ans) au Conseil d'administration, sans mettre à jour sa déclaration d'intérêts. Il a ainsi "omis" de préciser qu'il occupait des fonctions éminentes pour une société anglaise et une société chinoise, dont les produits dépendaient précisément de l'Agence. </p>
<p class="contents">Dans ces conditions, j'ai voté contre la décharge budgétaire de cette agence. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0058"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/127330.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Tania González Peñas (GUE/NGL), </span></span>  <span class="italic">por escrito. ‒ </span>Se ha votado a favor de la aprobación la gestión y del cierre de cuentas al no encontrarse irregularidades reseñables. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0062"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/23816.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">András Gyürk (PPE), </span></span>  <span class="italic">írásban. ‒ </span>Az Európai Számvevőszék 2014-es pénzügyi évre vonatkozó éves jelentésének bemutatását követően a 2014. évi zárszámadási eljárás keretében az Európai Parlament Költségvetési Ellenőrző Bizottsága elvégezte az Európai Unió általános költségvetésének az Európai Gyógyszerügynökségre vonatkozó pénzügyi ellenőrzését. A szakbizottság elsődleges feladata a közösségi költségvetés végrehajtásának szabályosságát és hatékonyságát biztosítani, ellenőrizni. A Számvevőszék megállapította, hogy a vizsgálatok során kellő mértékben megbizonyosodott arról, hogy az Európai Gyógyszerügynökség 2014-es pénzügyi évre vonatkozó éves beszámolója megbízható, és hogy az annak alapjául szolgáló ügyletek jogszerűek és szabályszerűek voltak. </p>
<p class="contents">A zárszámadási jelentés megállapítja, hogy a pénzügyi átvilágítás rendben lezajlott és a vizsgálat során nagyobb hiányosságokat nem tapasztaltak. A plenáris szavazáson a mentesítés megadását támogattam.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0125"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96907.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Τάκης Χατζηγεωργίου (</span></span>  <span class="bold">GUE</span><span class="bold">/</span><span class="bold">NGL</span><span class="bold">), </span><span class="italic">γραπτώς. ‒ </span>Ψηφίσαμε υπέρ της υπό εξέταση έκθεσης για την απαλλαγή και το κλείσιμο των λογαριασμών που αφορούσε την Ευρωπαϊκή Επιτροπή και τους εκτελεστικούς οργανισμούς δεδομένου ότι τα συστήματα εποπτείας και ελέγχου που απαιτεί ο δημοσιονομικός κανονισμός και οι πράξεις που ελέγχθηκαν ήταν απαλλαγμένες από ουσιώδη σφάλματα νομιμότητας και κανονικότητας. Επιπρόσθετα, η έκθεση ενισχύθηκε με τροπολογίες της Ομάδας μας που άπτονταν της καλύτερης δημοκρατικής λογοδοσίας των οργανισμών ενώ παράλληλα εισήχθησαν επαρκή μέτρα για να αποφευχθεί ο επηρεασμός των οργανισμών από τα λόμπυ των μεγάλων επιχειρήσεων.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0140"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/28116.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Marian Harkin (ALDE), </span></span>  <span class="italic">in writing. ‒ </span>I was happy to vote in favour of the Committee on Budgetary Control's report authored by Derek Vaughan on discharge in respect of the implementation of the budget of the European Medicines Agency. The work of the EMA is vital throughout the EU. However, I also support the general recommendations found in the Draft resolution on performance, financial management and control of EU agencies, which notes the increase in in the Agency's budget and the Agency's revised policy on handling of declarations of interests of scientific committee members and experts. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0156"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/118658.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Brian Hayes (PPE), </span></span>  <span class="italic">in writing. ‒ </span>I gave my support to this discharge as I had no problems with the agency's budget report. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0163"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124715.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">György Hölvényi (PPE), </span></span>  <span class="italic">írásban. ‒ </span>Az Európai Számvevőszék 2014-es pénzügyi évre vonatkozó éves jelentésének bemutatását követően a 2014. évi zárszámadási eljárás keretében az Európai Parlament Költségvetési Ellenőrző Bizottsága elvégezte az Európai Unió általános költségvetésének az Európai Gyógyszerügynökségre vonatkozó pénzügyi ellenőrzését. A szakbizottság elsődleges feladata a közösségi költségvetés végrehajtásának szabályosságát és hatékonyságát biztosítani, ellenőrizni. A Számvevőszék megállapította, hogy a vizsgálatok során kellő mértékben megbizonyosodott arról, hogy az Európai Gyógyszerügynökség 2014-es pénzügyi évre vonatkozó éves beszámolója megbízható, és hogy az annak alapjául szolgáló ügyletek jogszerűek és szabályszerűek voltak. </p>
<p class="contents">A zárszámadási jelentés megállapítja, hogy a pénzügyi átvilágítás rendben lezajlott és a vizsgálat során nagyobb hiányosságokat nem tapasztaltak. A szakbizottság április eleji ülésén a mentesítés megadásáról, a 2014-es számlák lezárásáról döntött. A plenáris szavazáson a mentesítés megadását támogattam.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0171"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96857.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Cătălin Sorin Ivan (S&amp;D), </span></span>  <span class="italic">în scris. ‒ </span>Comisia Europeană este responsabilă pentru executarea bugetului Uniunii Europene. Aceasta implică statele membre cărora Comisia le deleagă sarcini de punere în aplicare legate de o parte semnificativă a bugetului. În fiecare an, procedura de descărcare de gestiune asigură un control ex-post democratic la nivel politic, arătându-se astfel modul în care s-a utilizat bugetul anual al UE. </p>
<p class="contents">Am votat în favoarea acestui raport al descărcării generale de gestiune 2014 privind Agenția Europeană pentru Medicamente (EMA), prin care se solicită o poziție mai vigilentă a Comisiei cu privire la descărcarea de gestiune, solicitând acesteia să controleze mai frecvent ariile în care au fost alocați banii și care prezintă un risc ridicat de erori, să se concentreze pe controalele ex-ante, să colaboreze mai eficient cu statele membre pentru a corecta erorile înaintea declarării cheltuielilor și să introducă mai multă transparență și flexibilitate în ceea ce privește creditele neutilizate.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0172"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124754.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Ivan Jakovčić (ALDE), </span></span>  <span class="italic">napisan. ‒ </span>Glasao sam za Izvješće o razrješnici za izvršenje proračuna Europske agencije za lijekove za financijsku godinu 2014., zbog toga što je proračunsko i financijsko upravljanje provedeno u skladu s pravilima te je rezultiralo stopom izvršenja proračuna od 94,32 %. Takvo što predstavlja smanjenje stope izvršenosti u odnosu na 2013. godinu, te nisu ustanovljene znatne manjkavosti u poslovanju Agencije. </p>
<p class="contents">Podržavam unaprjeđenje postupaka zapošljavanja i planiranja resursa koji su poduzeti, te aktivnosti koje su se pokrenute kako bi se podigla razina transparentnosti poslovanja Agencije. Osviještenost politike sukoba interesa ključna je kako bi se osiguralo učinkovito i dosljedno poslovanje.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0173"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124770.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Jean-François Jalkh (ENF), </span></span>  <span class="italic">par écrit. ‒ </span>L'Agence européenne du médicament a consommé un budget 2014 de 282M d’euros, soit une augmentation de 13 %, et emploie 580 personnes. Seuls 12 % de son budget sont issus de l'Union, le reste provient de l'industrie pharmaceutique qui sollicite les autorisations, ce qui est déjà problématique puisque cela crée un lien de dépendance et obère son objectivité. Ainsi, le Pr Nistico, qui a présidé l'agence durant trois mandats, occupait dans le même temps des responsabilités dans une firme anglaise, dont les médicaments sont étudiés dans l'agence. J'ai donc voté contre. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0175"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124939.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Diane James (EFDD),</span></span>   <span class="italic">in writing</span><span class="bold">. –</span> UKIP voted against the discharge votes for multiple reasons. Primarily we are against the EU spending taxpayers’ money therefore we do not consent to this money being spent. Second of all, the lack of transparency in these procedures is of real concern to us. Finally many of these discharge reports call for a motion for resolution which requires further EU engagement which we are principally against.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0179"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96884.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Philippe Juvin (PPE), </span></span>  <span class="italic">par écrit. ‒ </span>J’ai voté en faveur de ce rapport qui octroie la décharge au directeur exécutif de l’Agence européenne des médicaments (EMA) sur l’exécution du budget pour l'exercice 2014.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0183"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125024.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Barbara Kappel (ENF), </span></span>  <span class="italic">schriftlich. ‒ </span>Ich stimme für die Entschließung und Entlastungsempfehlung zu EMA. Der Berichterstatter legt klar die Situation dar und hat meiner Meinung nach die richtige Entscheidung getroffen. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0185"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124962.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Afzal Khan (S&amp;D), </span></span>  <span class="italic">in writing. ‒ </span>I voted in favour of the discharge. The 32 decentralised Agencies of the EU are vitally important in terms of delivering the goals and results of EU policies. There is now good progress being made in terms of the agencies sharing best practice and, where feasible, support services. Their network is strong and they are working with the Commission to implement the Roadmap on Decentralised Agencies. This is of clear benefit to EU citizens and their performance is improving year on year.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0186"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124824.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Bernd Kölmel (ECR), </span></span>  <span class="italic">schriftlich. ‒ </span>In einer Situation, in der reiche Staaten wie Deutschland ihre Rentensysteme mittel- und langfristig nicht mehr finanzieren werden können, sind rasante Reformschritte nötig. Statt wie Wolfgang Schäuble über die Erhöhung des Rentenalters nachzudenken, fordert ALFA eine detaillierte Überprüfung der Haushaltsausgaben, einschließlich des deutschen Beitrags in den EU-Haushalt.</p>
<p class="contents">ALFA setzt sich für einen effizienteren EU-Haushalt ein und wendet sich entschieden gegen die Verschwendung von Steuergeldern, die auf nationalstaatlicher ähnlich wie auf der EU-Ebene ein großes Problem ist. Eine solche Einstellung erwartet ALFA vom ganzen Europäischen Parlament, das die Entlastung zum EU-Budget erteilt.</p>
<p class="contents">Da die Entwürfe des Ausschusses für Haushaltskontrolle generell eine Reform des EU-Budgets nicht stark genug gefordert hatten, habe ich gegen die Entlastung bei den meisten EU-Haushaltslinien gestimmt. Dies betraf auch die Entlastung zur Europäischen Arzneimittel-Agentur (EMA).</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0187"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96829.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Ádám Kósa (PPE), </span></span>  <span class="italic">írásban. ‒ </span>Az Európai Számvevőszék 2014-es pénzügyi évre vonatkozó éves jelentésének bemutatását követően a 2014. évi zárszámadási eljárás keretében az Európai Parlament Költségvetési Ellenőrző Bizottsága elvégezte az Európai Unió általános költségvetésének az Európai Gyógyszerügynökségre vonatkozó pénzügyi ellenőrzését. A szakbizottság elsődleges feladata a közösségi költségvetés végrehajtásának szabályosságát és hatékonyságát biztosítani, ellenőrizni. A Számvevőszék megállapította, hogy a vizsgálatok során kellő mértékben megbizonyosodott arról, hogy az Európai Gyógyszerügynökség 2014-es pénzügyi évre vonatkozó éves beszámolója megbízható, és hogy az annak alapjául szolgáló ügyletek jogszerűek és szabályszerűek voltak. </p>
<p class="contents">A zárszámadási jelentés megállapítja, hogy a pénzügyi átvilágítás rendben lezajlott és a vizsgálat során nagyobb hiányosságokat nem tapasztaltak. A szakbizottság április eleji ülésén a mentesítés megadásáról, a 2014-es számlák lezárásáról döntött. A szakbizottsági szavazáson és a plenáris szavazáson is a mentesítés megadását támogattam.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0194"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96816.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Giovanni La Via (PPE), </span></span>  <span class="italic">per iscritto. ‒ </span>Esprimo il mio voto in favore della proposta di decisione sul discarico dell'EMA (Agenzia europea per i medicinali) sulla base dell'attenta valutazione posta in essere dalla Corte dei conti. L'Agenzia, che persegue importanti obiettivi in materia di salute pubblica, e che opera sotto l'egida della commissione ENVI, ha correttamente implementato il bilancio e rendicontato le attività secondo regole di correttezza e sana gestione finanziaria. Per le motivazioni elencate e dopo un'attenta analisi del documento redatto dalla Corte dei conti, ritengo di votare a favore della concessione del discarico per il bilancio 2014.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0202"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/28210.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Marine Le Pen (ENF), </span></span>  <span class="italic">par écrit. ‒ </span>J’ai voté contre l’octroi de la décharge à l’Agence européenne des médicaments (EMA). La Cour des comptes donne blanc-seing à l'Agence pour la fidélité de ses comptes. En revanche, elle souligne plusieurs points préoccupants: le passage d'un contrat de consultance pour 15 millions d’euros sans informer le conseil d'administration, le non-respect des échéances pour appeler les paiements des laboratoires et régler les agences nationales ou encore des insuffisances en matière de contrôle de gestion. On peut également noter un lourd conflit d'intérêts, mais dont le Parlement a été informé par l'Agence elle-même. Le Pr Nistico a représenté le Parlement durant trois mandats (9 ans) au Conseil d'administration sans mettre à jour sa déclaration d'intérêt. Il a ainsi "omis" de préciser qu'il occupait des fonctions éminentes pour une société anglaise et une société chinoise dont les produits dépendent précisément de l'Agence. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0204"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124738.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Gilles Lebreton (ENF), </span></span>  <span class="italic">par écrit. ‒ </span>J’ai voté contre ce rapport qui donne décharge. L'Agence européenne du médicament délivre les autorisations de mise sur le marché de classes de médicaments spécifiques (anticancéreux, anti-VIH, médicaments issus du génie génétique comme les vaccins controversés contre le cancer du col de l'utérus, Gardasil et Cervarix...). Or, il est fait état d’un lourd conflit d'intérêts. En effet, le Pr Nistico a représenté le Parlement durant trois mandats (9 ans) au Conseil d'administration sans mettre à jour sa déclaration d'intérêt. Il a ainsi "omis" de préciser qu'il occupait des fonctions éminentes pour une société anglaise et une société chinoise dont les produits dépendent précisément de l'Agence. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0205"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125684.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Philippe Loiseau (ENF), </span></span>  <span class="italic">par écrit. ‒ </span>La décharge budgétaire de l'exercice 2014 tend à libérer de toute responsabilité l'Agence européenne du Médicament (EMA) pour sa conduite financière. D'après le constat du rapporteur, l'Agence est fidèle à ses comptes, et fait figure de bon élève parmi l'ensemble des institutions européennes. Cependant, ayant pour rôle de délivrer les autorisations de mise sur le marché de médicaments spécifiques (comme les anticancéreux, anti-VIH...), elle subit des pressions de nombreux lobbyistes. Elle est, entre autres, marquée par un important conflit d'intérêt avec le cas du Dr Nistico qui, tout en représentant le Parlement pendant trois ans, occupait des postes importants dans une société anglaise et chinoise. De ce fait, j'ai voté CONTRE.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0206"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124820.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Bernd Lucke (ECR), </span></span>  <span class="italic">schriftlich. ‒ </span>In einer Situation, wo reiche Staaten wie Deutschland ihre Rentensysteme mittel- und langfristig nicht mehr finanzieren werden können, sind deutliche Reformschritte nötig. Statt wie Wolfgang Schäuble über die Erhöhung des Rentenalters nachzudenken, fordert ALFA eine detaillierte Überprüfung der Haushaltsausgaben, einschließlich des deutschen Beitrags in den EU-Haushalt.</p>
<p class="contents">ALFA setzt sich für einen effizienteren EU-Haushalt ein und wendet sich entschieden gegen die Verschwendung von Steuergeldern, die auf nationalstaatlicher ähnlich wie auf der EU-Ebene ein großes Problem ist. Eine solche Einstellung erwartet ALFA von dem ganzen Europaparlament, das die Entlastung zum EU-Budget erteilt.</p>
<p class="contents">Da die Entwürfe des Ausschusses für Haushaltskontrolle generell eine Reform des EU-Budgets nicht deutlich genug gefordert hatten, habe ich gegen die Entlastung bei den meisten EU-Haushaltslinien gestimmt. Dies betraf auch die Entlastung zur Europäischen Arzneimittel-Agentur (EMA).</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0208"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/84175.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Petr Mach (EFDD), </span></span>  <span class="italic">písemně. ‒ </span>Nesouhlasím s navyšováním rozpočtu této agentury.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0210"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/119436.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Ivana Maletić (PPE), </span></span>  <span class="italic">napisan. ‒ </span>U izvješću Revizorskog suda za financijsku godinu 2014. utvrđeno je kako nema nepravilnosti u računovodstvenoj dokumentaciji Europske agencije za lijekove. Temeljem izvješća Revizorskog suda, podržala sam Izvješće o davanju razrješnice izvršnom direktoru EMA-e za izvršenje proračuna za financijsku godinu 2014. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0214"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124746.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Andrejs Mamikins (S&amp;D), </span></span>  <span class="italic">rakstiski. ‒ </span>Eiropas Zāļu aģentūras galvenais uzdevums ir sabiedrības un dzīvnieku veselības aizsardzība un veicināšana, realizējot cilvēku un veterināro zāļu novērtēšanu un uzraudzību. Svarīgi atzīmēt, ka tieši <span class="italic">EMA</span> ir atbildīga par pieteikumu Eiropas zāļu reģistrācijas apliecības saņemšanai zinātnisko novērtēšanu. Citiem vārdiem, bez <span class="italic">EMA</span> atļaujas nevienas zāles nevar tikt legāli pārdotas ES dalībvalstu teritorijā.</p>
<p class="contents">2014. gadā Aģentūras budžets sastādīja 282,474 miljonus euro — par 12,29 % vairāk nekā 2013. gadā. Tikai 12,53 % no <span class="italic">EMA</span> budžeta tika finansēti no Savienības budžeta. Izpildes līmenis bija 94,32 % — par 2,44 % mazāks nekā gadu iepriekš.</p>
<p class="contents">Viennozīmīgi pievienojos bažu izteikšanai par to, ka bez attiecīgas apstiprināšanas no Komisijas vai Parlamenta puses <span class="italic">EMA</span> 2014. gada martā sāka izmēģinājuma projektu par adaptīvo licencēšanu, kas faktiski varētu novest līdz situācijai, kad zāles saņem licences jau pēc iziešanas kopienas tirgū, kas vienkārši nav pieļaujams.</p>
<p class="contents">Gan pēc fakta, gan ņemot vērā darbības jomu, <span class="italic">EMA</span> viennozīmīgi jānodrošina maksimāla pārredzamība piekļuvē klīniskajiem ziņojumiem, kas attiecas arī uz informācijas sniegšanu par visiem Aģentūras veiktā darba aspektiem.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0216"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125069.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Νότης Μαριάς (ECR), </span></span>  <span class="italic">γραπτώς. ‒ </span>Για λόγους έλλειψης: α) πλήρους διαφάνειας, β) σοβαρής τεκμηρίωσης, γ) αξιοπιστίας, δ) επαρκών στοιχείων αναφορικά με την εκτέλεση του υπό ψήφιση προϋπολογισμού του οικείου Οργανισμού, καταψηφίζω την έκθεση σχετικά με την απαλλαγή όσον αφορά την εκτέλεση του προϋπολογισμού του Ευρωπαϊκού Οργανισμού Φαρμάκων για το οικονομικό έτος 2014.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0217"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124751.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Dominique Martin (ENF), </span></span>  <span class="italic">par écrit. ‒ </span></p>
<p class="contents">J'ai voté contre l'octroi de la décharge.</p>
<p class="contents">Avec un budget de 282 millions d'euros (en hausse de 13 % par rapport à 2013) et un effectif de 580 personnes, l'EMA a vocation à délivrer des autorisations de mise sur le marché de médicaments spécifiques : anticancéreux, antirétroviraux, etc.</p>
<p class="contents">Son indépendance est sujette à caution. En effet, seuls 12 % de son budget proviennent du budget européen. Le reste provient de financements privés.</p>
<p class="contents">La Cour des comptes souligne, en outre, de nombreuses insuffisances en matière de paiements et de contrôle de gestion. </p>
<p class="contents">Un dossier de conflit d'intérêts concernant le Professeur Nistico est en cours. Ce dernier a représenté le Parlement au sein de l'EMA pendant trois mandats. Dans le même temps, il travaillait pour deux sociétés pharmaceutiques.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0218"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96742.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Jean-Luc Mélenchon (GUE/NGL), </span></span>  <span class="italic">par écrit. ‒ </span>Ce rapport propose de donner quitus pour l’exécution du budget 2014 de l'Agence européenne des médicaments (EMA). Je m’étais opposé au cadre général de ce budget lors de son vote en 2013. Les points sur lesquels j’avais alors alerté se sont tous vérifiés. Et les engagements intenables pris alors par les institutions européennes n’ont pas été tenus. 2014 devait en particulier être l’année de la résorption finale de tous les impayés de l’UE, dont certains s’accumulent depuis 9 ans. Une tâche impossible avec un budget en baisse de 6 % (moins 10 milliards), même en consacrant plus de la moitié des crédits de paiements de l’année 2014 au paiement des engagements pris les années précédentes. Résultat: les impayés sont toujours là (estimés à 2 milliards fin 2016) et les besoins budgétaires d’avenir ne sont pas couverts. Je confirme mon opposition à ce cadre budgétaire d’austérité en votant contre cette décharge.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0222"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124765.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Joëlle Mélin (ENF), </span></span>  <span class="italic">par écrit. ‒ </span>La gestion de l'Agence des médicaments a manqué de transparence et des petits écarts laxistes aux règles ont été relevés. De plus, un conflit d'intérêt de taille – pour lequel l'Agence a alerté le Parlement – s'est produit autour d'un certain Professeur Pico qui aurait omis de mettre à jour sa déclaration d'intérêt.</p>
<p class="contents">En conséquence, j'ai voté contre la décharge.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0226"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96978.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Nuno Melo (PPE), </span></span>  <span class="italic">por escrito. ‒ </span>Todas as instituições europeias que dependem do orçamento da União Europeia têm que ser fiscalizadas, de forma rigorosa. É necessário aferir se os fundos comunitários estão a ser bem utilizados, se essas instituições estão a cumprir com os objetivos delineados e se não existe desperdício de recursos.</p>
<p class="contents">De um modo geral, salvo raras exceções, a avaliar pelas fiscalizações conhecidas, podemos afirmar que as instituições em causa estão a utilizar de forma correta os fundos disponibilizados e a cumprir com os objetivos propostos.</p>
<p class="contents">Votei a favor.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0230"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/118859.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Roberta Metsola (PPE), </span></span>  <span class="italic">in writing. ‒ </span>Following the recommendation from the Council, the declaration of assurance from the Court of Auditors and the report from the Committee of Budgetary Control, I chose to support the decision regarding the discharge on the implementation of the budget of the European Medicines Agency for the financial year 2014.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0234"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/118858.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Marlene Mizzi (S&amp;D), </span></span>  <span class="italic">in writing. ‒ </span>I voted in favour of granting discharge of the European Medicines Agency in respect of the implementation of the Authority’s budget for the financial year 2014, because the final accounts of the European Medicines Agency are as annexed to the Court of Auditors’ report and because I agree with the closure of the accounts of the European Institute of Innovation and Technology for the financial year 2014.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0236"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124722.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Csaba Molnár (S&amp;D), </span></span>  <span class="italic">írásban. ‒ </span>Az Európai Gyógyszerügynökség benyújtotta a 2014-es pénzügyi évre vonatkozó végleges éves beszámolóját. A Tanács, a Számvevőszéknek az éves beszámolóról szóló jelentése alapján 2016. február 12-én ajánlást tett a Parlamentnek, hogy az Ügynökség ügyvezető igazgatóját mentesítse az ügynökség 2014-es pénzügyi évre szóló költségvetése végrehajtására vonatkozó felelősség alól. A Költségvetési Ellenőrző Bizottság jelentésében azt javasolta, hogy a Parlament ezt a mentesítést adja meg. Ennek megfelelően szavaztam.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0238"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124734.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Cláudia Monteiro de Aguiar (PPE), </span></span>  <span class="italic">por escrito. ‒ </span>Pelo exposto no presente relatório, o mesmo merece o meu voto favorável no sentido de dar quitação ao Diretor Executivo da Agência Europeia de Medicamentos pela execução do orçamento da Agência para o exercício de 2014.</p>
<p class="contents">Defendo que as observações/sugestões apresentadas devem ser tidas em consideração futuramente.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0242"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124769.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Sophie Montel (ENF), </span></span>  <span class="italic">par écrit. ‒ </span>Au vu des problèmes évoqués, le ton du rapport est clairement insuffisamment critique. Je vote contre.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0250"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/72779.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Nadine Morano (PPE), </span></span>  <span class="italic">par écrit. ‒ </span>Il s'agissait dans ce rapport de se prononcer sur la décharge budgétaire 2014 pour l'Agence européenne des médicaments, qui joue un rôle fondamental dans la protection et la promotion de la santé publique et animale. La décharge budgétaire, qui peut être accordée, ajournée ou refusée par le Parlement européen, constitue le contrôle final du budget annuel. Le processus de décharge représente le volet politique du contrôle de l’exécution budgétaire. </p>
<p class="contents">Dans le cas de l'EMA, la Cour des comptes estime avoir obtenu des assurances raisonnables que les comptes de l'Agence pour l'exercice 2014 étaient fiables et que les opérations financières étaient légales et régulières. Je me suis appuyée sur l'avis de la Cour des comptes. J'ai donc voté en faveur de l'accord de la décharge, le budget ayant été exécuté sans erreur significative. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0375"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124729.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Renaud Muselier (PPE), </span></span>  <span class="italic">par écrit. ‒ </span>La Cour des comptes ayant donné une opinion positive sur la fiabilité des comptes et sur la fiabilité et la régularité des transactions sous-jacentes, j'ai voté en faveur de la décharge. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0437"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/88882.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Victor Negrescu (S&amp;D), </span></span>  <span class="italic">in writing. ‒ </span>Ultimately responsible for the execution of the European Union's budget is the European Commission. The decision on whether to grant discharge for the execution of the EU budget is made by the European Parliament. The discharge procedure ensures ex-post democratic oversight at political level of how the EU's annual budget has been used. It aim is to verify that the implementation was in accordance with relevant rules and principles of sound financial management. The report underlines that the EU funding must be efficient in advancing EU goals, project should be aligned with the EU policies and better synergy should be achieved between all available resources in the fields, such as neighborhood policy, external aid, and tackling the youth unemployment. </p>
<p class="contents">I have voted for this report on European Medicines Agency (EMA) discharge that calls for a more vigilant position on the discharge, asking the Commission to control more frequently areas and recipients with high risk of errors, focus on ex-ante controls, collaborate with the member states to correct errors before declaring expenditure and introduce more transparency and flexibility in spending so that unused appropriations could be used for new priorities.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0468"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124784.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Dan Nica (S&amp;D), </span></span>  <span class="italic">în scris. ‒ </span>Agenția Europeană pentru Medicamente este un organism descentralizat al Uniunii Europene responsabil de protecția și promovarea sănătății publice și a animalelor, prin intermediul evaluării și supravegherii medicamentelor destinate uzului uman și veterinar. EMA este responsabilă de evaluarea științifică a cererilor de autorizație europeană de punere pe piață a produselor medicinale.</p>
<p class="contents">Am votat pentru acordarea descărcării de gestiune deoarece, în conformitate cu raportul anual de activitate, precum și cu constatările Curții de Conturi, nivelul și natura transferurilor în 2014 s-au menținut în limitele normelor financiare.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0476"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124987.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Liadh Ní Riada (GUE/NGL),</span></span>   <span class="italic">in writing</span><span class="bold">. </span>– I voted in favour of the granting of this discharge which was concerned with the European Medicines Agency (EMA).</p>
<p class="contents">There were no special irregularities which would justify a postponement.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0484"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/129073.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Urmas Paet (ALDE), </span></span>  <span class="italic">kirjalikult. ‒ </span>Toetasin. Tegemist on eelarve täitmise heakskiitmisega.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/36392.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Aldo Patriciello (PPE), </span></span>  <span class="italic">per iscritto. ‒ </span>Visti i conti annuali definitivi e la relazione della Corte dei conti, mi sento di approvare la concessione del discarico al direttore esecutivo dell'Agenzia europea per i medicinali per l'esecuzione del bilancio dell'Agenzia per l'esercizio 2014. Voto quindi positivamente.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0625"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124749.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Marijana Petir (PPE), </span></span>  <span class="italic">napisan. ‒ </span>Glavni zadatak Europske agencije za lijekove je zaštita i unapređenje zdravlja ljudi i životinja nadzorom nad lijekovima koji se koriste u medicinske i veterinarske svrhe. Jedna od najvažnijih aktivnosti je nadzor nad lijekovima nakon njihovog odobrenja na način da agencija prima sigurnosna izvješća iz Unije i izvan nje, te koordinira akcije koje pridonose kvaliteti i sigurnosti lijekova. </p>
<p class="contents">Agencija također ispituje certifikate medicinskih proizvoda u sklopu naputaka koje izdaje Svjetska zdravstvena organizacija. Druga je aktivnost inspekcijski nadzor nad kliničkom praksom, laboratorijskim radom, proizvodnjom i izdavanjem certifikata za medicinske proizvode, te nadzor nad kvalitetom i postupanje u slučaju da se utvrde nedostaci tih proizvoda. Prema financijskim izvješćima, konačni proračun Europske agencije za lijekove u 2014. godini iznosio je 282 474 000 eura, što je povećanje od 12,29 % u odnosu na 2013. </p>
<p class="contents">Iz proračuna Unije potječe 12,53 % proračuna Agencije. Revizorski sud u svojem izvješću o godišnjoj računovodstvenoj dokumentaciji Europske agencije za lijekove za financijsku godinu 2014. izjavljuje da je stekao razumno uvjerenje da je godišnja računovodstvena dokumentacija Agencije za financijsku 2014. godinu pouzdana te da su osnovne transakcije zakonite i pravilne. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0687"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/110977.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Florian Philippot (ENF), </span></span>  <span class="italic">par écrit. ‒ </span>L'Agence européenne du médicament a consommé un budget 2014 de 282M euros (+13 %) et emploie 580 personnes. Seuls 12 % de son budget sont issus de l'Union, le reste provient de l'industrie pharmaceutique qui sollicite les autorisations, ce qui est déjà problématique puisque cela crée un lien de dépendance et obère son objectivité, mais l'Agence n'en est pas responsable. Ratio budget/emploi: 486 k euros/personne. La Cour des comptes donne blanc-seing à l'Agence pour la fidélité de ses comptes. En revanche, elle souligne plusieurs points préoccupants : le passage d'un contrat de consulting pour 15M euros sans informer le conseil d'administration (même si c'est conforme aux statuts de l'agence), le non-respect des échéances pour appeler les paiements des laboratoires et régler les agences nationales ou encore des insuffisances en matière de contrôle de gestion. On peut également noter un lourd conflit d'intérêts, mais dont le Parlement a été informé par l'Agence elle-même. Le Pr Nistico a représenté le Parlement durant trois mandats (9 ans) au Conseil d'administration sans mettre à jour sa déclaration d'intérêt. Il a ainsi "omis" de préciser qu'il occupait des fonctions éminentes pour une société anglaise et une société chinoise dont les produits dépendent précisément de l'Agence. Dans ces conditions, je vote contre le rapport et la décharge.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/112744.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Tonino Picula (S&amp;D), </span></span>  <span class="italic">napisan. </span><span class="italic">‒ </span>Europski parlament je, uzimajući u obzir članak 319. Ugovora o funkcioniranju Europske unije i izvješće Odbora za proračunski nadzor i mišljenje Odbora za okoliš, javno zdravlje i sigurnost hrane, dao razrješnicu izvršnom direktoru Europske agencije za lijekove za izvršenje proračuna Agencije za financijsku godinu 2014.</p>
<p class="contents">Utvrdio je da konačna godišnja računovodstvena dokumentacija Europske agencije za lijekove odgovara obliku u kojemu je sadržana u prilogu izvješću Revizorskog suda, te je odobrio zaključenje poslovnih knjiga Europske agencije za lijekove za financijsku godinu 2014.</p>
<p class="contents">Primjećujem da su napori u praćenju proračuna tijekom financijske godine 2014. rezultirali stopom izvršenja proračuna od 94,32 %. Međutim, izražavam žaljenje što to predstavlja smanjenje od 2,44 % u usporedbi s prethodnom godinom</p>
<p class="contents">Pohvalio bih činjenicu da je 580 od 599 slobodnih radnih mjesta popunjeno do kraja 2014. te da je Agencija zaposlila 210 ugovornih zaposlenika, ustupljenih nacionalnih stručnjaka i zaposlenika zaposlenih posredovanjem zavoda za zapošljavanje.</p>
<p class="contents">Slijedom svega navedenog, pozdravljam Odluku Europskog parlamenta kojom je dao razrješnicu izvršnom direktoru Europske agencije za lijekove za izvršenje proračuna Agencije za financijsku godinu 2014., iako smatram da praćenje utjecaja lijekova na ljudski organizam nije dovoljno pokriveno.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0875"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/108080.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Franck Proust (PPE), </span></span>  <span class="italic">par écrit. ‒ </span></p>
<p class="contents">J'ai voté en faveur de l'octroi de la décharge relative à l'exécution du budget de l'Agence européenne des médicaments (EMA) dans le cadre de l'exercice de 2014. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0906"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/106202.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Julia Reid (EFDD), </span></span>  <span class="italic">in writing. ‒ </span>UKIP voted against the discharge votes for multiple reasons. Primarily we are against the EU spending taxpayers’ money therefore we do not consent to this money being spent. Second of all, the lack of transparency in these procedures is of real concern to us. Finally many of these discharge reports call for a motion for resolution which requires further EU engagement which we are principally against.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0921"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125043.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Inmaculada Rodríguez-Piñero Fernández (S&amp;D), </span></span>  <span class="italic">por escrito. ‒ </span>He dado mi apoyo a este informe por el que se aprueba la gestión del director ejecutivo de la Agencia Europea de Medicamentos en la ejecución del presupuesto de la Agencia para el ejercicio 2014 a la vista del informe del Tribunal de Cuentas, en que declara haber obtenido garantías razonables sobre la fiabilidad de las cuentas anuales de la Agencia para el ejercicio 2014 y la legalidad y la regularidad de las operaciones correspondientes y en el que observa que los esfuerzos de supervisión del presupuesto durante el ejercicio 2014 dieron lugar a un porcentaje de ejecución presupuestaria del 94,32%, una disminución del 2,44 % en comparación con el ejercicio anterior. Igualmente, constata que la Agencia aumentó la transparencia en cuanto a sus procedimientos de selección de personal haciendo público el estado de los procedimientos externos en curso y el estado de las listas de reserva en la página web externa de la Agencia, y que también mejoró la documentación relativa a estos procedimientos.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0929"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125107.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Claude Rolin (PPE), </span></span>  <span class="italic">par écrit. ‒ </span>J'ai voté en faveur de cette décharge 2014 (qui fait suite à la présentation du rapport de la Cour des comptes européenne pour l’exercice 2014) notamment parce que la Cour des comptes avait émis une opinion sans réserve (c'est-à-dire positive) pour cette agence concernant la fiabilité de ses comptes ainsi que la légalité et la régularité des opérations sous-jacentes. Il est à noter que la Cour des comptes a souligné que, dans l'ensemble, pour les 32 agences de l'Union européenne, elle avait relevé moins de problèmes dans les agences que les années précédentes et que, dès lors, ses rapports comportaient moins d'observations. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0933"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125214.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Bronis Ropė (Verts/ALE), </span></span>  <span class="italic">raštu. ‒ </span>Balsavau už šį pranešimą, kuriuo tvirtinamas 2014 finansinių metų Europos vaistų agentūros biudžeto įvykdymas. Agentūros 2014 finansinių metų biudžetas buvo 282 474 000 EUR, t. y. 12,29 proc. didesnis nei 2013 m. 12,53 proc. Agentūros biudžetą sudaro lėšos iš Sąjungos biudžeto. 2014 finansiniais metais biudžeto įvykdymo lygis buvo 94,32 proc., t. y. 2,44 proc. mažesnis nei ankstesniais metais.</p>
<p class="contents">Agentūra padidino įdarbinimo procedūrų skaidrumą, nes savo interneto svetainėje skelbia informaciją apie vykdomų išorės procedūrų ir rezervo sąrašų padėtį. 2014 m. gruodžio mėn. Agentūros valdančioji taryba patvirtino kovos su sukčiavimu strategiją.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0935"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125035.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Lola Sánchez Caldentey (GUE/NGL), </span></span>  <span class="italic">por escrito. ‒ </span> Se ha votado a favor de la aprobación la gestión y del cierre de cuentas al no encontrarse irregularidades reseñables. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0937"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125049.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Maria Lidia Senra Rodríguez (GUE/NGL), </span></span>  <span class="italic">por escrito. ‒ </span>He votado en contra de la presente descarga presupuestaria en favor de la Agencia Europea de Medicamentos porque, pese a cumplir con los requerimientos formales y procedimentales, esta Autoridad es la encargada de defender los intereses de la industria farmacéutica europea que mantiene fuertes bloqueos en el acceso a los medicamentos genéricos. Me he abstenido en la resolución porque aprueba los aspectos formales de la gestión de la Autoridad y señala algunas fallas de su funcionamiento durante el ejercicio de 2014. Pero hemos votado en contra de la descarga financiera porque la dirección política de esta Agencia en 2014, ha sido el boqueo sistemático en el acceso a nuevos medicamentos genéricos que hubieran permitido garantizar el acceso a numerosos tratamientos a los ciudadanos y ciudadanas europeas.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0968"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124948.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Siôn Simon (S&amp;D), </span></span>  <span class="italic">in writing. ‒ </span>The EMA has been an important agency in terms of delivering the EU’s policy goals and results. There is now good progress being made in terms of this agency sharing best practice with other agencies and it has shown that it will, where feasible, support other services. This agency has proven that it is of clear benefit to EU citizens, performance is improving every year and it receives my support.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1393-0984"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124756.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Davor Škrlec (Verts/ALE), </span></span>  <span class="italic">napisan. ‒ </span>Podržao sam ovu razrješnicu, no ovo obrazloženje glasovanja nastaje kao kritika postojećem sustavu vrednovanja rada zastupnika u Europskom parlamentu isključivo na osnovu statističkog broja parlamentarnih aktivnosti potenciranog u Hrvatskoj, a koji zapravo ne odražava stvarnu kvalitetu i količinu rada, učinkovitost te ponajviše uspjeh zastupničkog djelovanja.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1394-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96655.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Monika Smolková (S&amp;D), </span></span>  <span class="italic">písomne ‒ </span>Podporila som udelenie absolutória výkonnému riaditeľovi Európskej agentúry pre lieky (EMA), keďže konečná ročná uzávierka agentúry bola schválená Dvorom audítorov. Podľa finančných výkazov predstavoval konečný rozpočet agentúry za rozpočtový rok 2014 sumu asi 282 mil. EUR, čo predstavuje nárast o 12,29 percenta v porovnaní s rokom 2013. Dvor audítorov vo svojej správe uvádza, že ročná účtovná závierka agentúry je spoľahlivá a že príslušné operácie sú zákonné a riadne. Agentúra zohráva dôležitú úlohu pri ochrane a podpore verejného zdravia a zdravia zvierat tým, že posudzuje lieky na humánne a veterinárne použitie a vykonáva nad nimi dohľad. Jednou z výziev, s ktorými sa musí agentúra vyrovnávať je zabezpečenie maximálnej transparentnosti v poskytovaní prístupu ku klinickým správam. Preto vítam, že agentúra zverejnila svoju revidovanú politiku v oblasti zaobchádzania s vyhláseniami o záujmoch členov vedeckých výborov a expertov. Táto revízia totiž odráža vyváženejší prístup k zaobchádzaniu s vyhláseniami o záujmoch. Vítam tiež, že agentúra začala spracovávať výročné environmentálne výkazníctvo a vypracovala stratégiu boja proti podvodom. Dúfam, že aj tieto opatrenia prispejú k transparentnému a objektívnemu prístupu ku kontrole liekov.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1394-0125"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125003.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Igor Šoltes (Verts/ALE), </span></span>  <span class="italic">pisno. ‒ </span>V okviru vsakoletnega proračunskega postopka, ki ob številnih pogajanjih in usklajevanjih lahko traja tudi do sedem mesecev, tri temeljne institucije EU sprejmejo evropski proračun za prihodnje leto. Za njegovo izvajanje so nato zadolžene Evropska komisija in druge institucije. Evropski parlament kot neposredno izvoljena institucija, ki zastopa davkoplačevalce EU, izvaja demokratični nadzor ter skrbi, da Komisija in druge institucije ustrezno ravnajo z evropskimi sredstvi.</p>
<p class="contents">Parlament v svojem letnem postopku razrešnice sklene, ali bo podelil razrešnico in dokončno odobril način, na katerega se je v posameznem letu izvrševal proračun. Parlament pred odločitvijo preuči priporočila Odbora za proračunski nadzor in pri tem upošteva tudi letno poročilo Računskega sodišča ter odgovore Komisije na poslanska vprašanja.</p>
<p class="contents">Poročilo poročevalca Dereka Vaughana navaja utemeljene razloge v prid podelitvi razrešnice EMA, zato sem ga pri glasovanju podprl.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1394-0187"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124827.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Joachim Starbatty (ECR), </span></span>  <span class="italic">schriftlich. ‒ </span></p>
<p class="contents">In einer Situation, wo reiche Staaten wie Deutschland ihre Rentensysteme mittel- und langfristig nicht mehr finanzieren werden können, sind deutliche Reformschritte nötig. Statt wie Wolfgang Schäuble über die Erhöhung des Rentenalters nachzudenken, fordert ALFA eine detaillierte Überprüfung der Haushaltsausgaben, einschließlich des deutschen Beitrags in den EU-Haushalt.</p>
<p class="contents">ALFA setzt sich für einen effizienteren EU-Haushalt ein und wendet sich entschieden gegen die Verschwendung von Steuergeldern, die auf nationalstaatlicher ähnlich wie auf der EU-Ebene ein großes Problem ist. Eine solche Einstellung erwartet ALFA von dem ganzen Europaparlament, das die Entlastung zum EU-Budget erteilt.</p>
<p class="contents">Da die Entwürfe des Ausschusses für Haushaltskontrolle generell eine Reform des EU-Budgets nicht deutlich genug gefordert hatten, habe ich gegen die Entlastung bei den meisten EU-Haushaltslinien gestimmt. Dies betraf auch die Entlastung zur Europäischen Arzneimittel-Agentur (EMA).</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1394-0218"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124929.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Ivan Štefanec (PPE), </span></span>  <span class="italic">písomne ‒ </span>Európsky parlament udelil Európskej agentúre pre lieky absolutórium za plnenie rozpočtu agentúry za rozpočtový rok 2014 a zároveň schválil účtovnú závierku. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1394-0250"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/119435.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Davor Ivo Stier (PPE), </span></span>  <span class="italic">napisan. ‒ </span>Europska agencija za lijekove (EMA) decentralizirano je tijelo Europske unije čija je glavna zadaća štititi i promicati javno zdravlje i zdravlje životinja na temelju ocjena i nadzora lijekova u humanoj i veterinarskoj medicini. Agencija je zadužena za znanstveno ocjenjivanje zahtjeva za odobrenje za stavljanje medicinskih proizvoda na europsko tržište. Revizorski sud u svojem je izvješću izjavio da je stekao razumno uvjerenje da je godišnja računovodstvena dokumentacija Agencije za financijsku godinu 2014. pouzdana te da su osnovne transakcije pravilne i u skladu sa zakonodavstvom EU-a. </p>
<p class="contents">Prema godišnjem izvješću o radu, kao i prema nalazima Revizorskog suda, razina i narav prijenosa tijekom 2014. ostale su u granicama financijskih pravila. Uočeni su bitni nedostaci u kontroli upravljanja, no uspostavljen je i proveden akcijski plan za rješavanje tog pitanja. Pozdravljam planove Agencije o unaprjeđivanju postupaka zapošljavanja i planiranja resursa kako bi se povećala razina ljudskih resursa dodijeljenih za operativne zadatke. Slijedom navedenog, podržavam ovo izvješće.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1394-0500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/119434.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Dubravka Šuica (PPE), </span></span>  <span class="italic">napisan. ‒ </span>Glavna zadaća Europske agencije za lijekove (EMA-e), čije je sjedište u Londonu, jest zaštita i promicanje javnog zdravlja i zdravlja životinja na temelju ocjena i nadzora lijekova u humanoj i veterinarskoj medicini. EMA je, između ostalog, zadužena za znanstveno ocjenjivanje zahtjeva za odobrenje za stavljanje medicinskih proizvoda na europsko tržište.</p>
<p class="contents">Podržavam izvješće kolege Vaughana o razrješnici za izvršenje proračuna Europske agencije za lijekove za financijsku godinu 2014. Revizorski sud je u svojem izvješću o godišnjoj računovodstvenoj dokumentaciji Europske agencije za lijekove za financijsku godinu 2014. utvrdio da je dokumentacija Agencije pouzdana te da su osnovne transakcije zakonite i pravilne. Isto tako, Sud nije otkrio ni jedan problem u području razine i naravi prijenosa tijekom 2014. godine koji su u granicama financijskih pravila. </p>
<p class="contents">Prenesena odobrena sredstva prvenstveno su se upotrijebila za pokrivanje troškova za razvoj informacijske tehnologije u poslovanju, za naknade za izvjestitelje i za druge prilagodbe administrativnih proračunskih stavki.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1394-0750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125103.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Patricija Šulin (PPE), </span></span>  <span class="italic">pisno. ‒ </span>Glasovala sem za poročilo o razrešnici glede izvrševanja proračuna Evropske agencije za zdravila za proračunsko leto 2014.</p>
<p class="contents">Po podatkih Računskega sodišča je Evropska agencija za zdravila imela težave z roki za plačilo pristojbin kandidatov in plačila pristojnim nacionalnim, saj le ti niso bili upoštevani. Zato agencijo upravičeno poziva k temu, naj sprejme vse nadaljnje ukrepe, ki so potrebni za zagotavljanje celovitega izvajanja njenih pristojnosti v zvezi s farmakovigilanco, in organu za podelitev razrešnice učinkovito poroča o ukrepih, ki jih je sprejela, da bi te težave odpravila.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1394-0875"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124703.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Tibor Szanyi (S&amp;D), </span></span>  <span class="italic">írásban. ‒ </span>Szavazatommal támogattam a mentesítést adó jelentést, mivel a Számvevőszék megállapította, hogy kellő mértékben megbizonyosodott az Európai Gyógyszerügynökség 2014-es pénzügyi évre vonatkozó éves beszámolójának megbízhatóságáról, valamint arról, hogy az annak alapjául szolgáló ügyletek jogszerűek és szabályszerűek. A pénzügyi kimutatások szerint az Európai Gyógyszerügynökség 2014-as pénzügyi évre szóló végleges költségvetése 282 474 000 euró volt, ami 2013-hoz képest 12,29%-os növekedést jelent, viszont az ügynökség költségvetésének csak12,53%-a származik az uniós költségvetésből.</p>
<p class="contents">A költségvetési rendelet értelmében az Ügynökség költségvetési bevétele az uniós hozzájárulásokból származó készpénzből, valamint a gyógyszerkészítmények forgalombahozatali engedélyére irányuló kérelmek, az engedélyezést követő tevékenységek, illetve a különböző adminisztratív tevékenységek után fizetendő díjakból tevődik össze. Örömtelinek tartom, hogy az ügynökség 2014 novemberében közzétette a tudományos bizottság tagjai és a szakértők összeférhetetlenségi nyilatkozatainak kezelésével kapcsolatos felülvizsgált politikáját, amely 2015 januárjában lépett hatályba. Ezen keresztül az ügynökség meghatározta a közvetlen és a közvetett érdekeltségek fogalmát, és minden szakértő számára előírta, hogy éves összeférhetetlenségi nyilatkozatunkban feltüntessék az esetükben fennálló valamennyi közvetlen és közvetett érdekeltséget.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1395-0000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/29579.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Marc Tarabella (S&amp;D), </span></span>  <span class="italic">par écrit. ‒ </span>J'ai vote en faveur de la décharge et tiens à souligner le travail important et de qualité effectué par les experts S&amp;D en ce qui concernent les amendements, les explications et durant les négociations.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1395-0250"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124706.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Pavel Telička (ALDE), </span></span>  <span class="italic">in writing. ‒ </span>I voted in favour of granting the European Medicines Agency discharge regarding the 2014 budget, as the budget was in compliance with the rules, and served ensure that the medecine developped by pharmaceutical companies for our use is safe.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1395-0375"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125104.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Romana Tomc (PPE), </span></span>  <span class="italic">pisno. ‒ </span>Poročilo o razrešnici glede izvrševanja proračuna Evropske agencije za zdravila sem podprla ob upoštevanju poročila Računskega sodišča o zaključnem računu Evropske agencije za zdravila za proračunsko leto 2014 z odgovori urada ter izjave o zanesljivosti računovodskih izkazov ter zakonitosti in pravilnosti z njimi povezanih transakcij, ki jo je za proračunsko leto 2014 v skladu s členom 287 Pogodbe o delovanju Evropske unije pripravilo Računsko sodišče.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1395-0406"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/131749.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Estefanía Torres Martínez (GUE/NGL), </span></span>  <span class="italic">por escrito. ‒ </span> Se ha votado a favor de la aprobación la gestión y del cierre de cuentas al no encontrarse irregularidades reseñables. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1395-0437"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124705.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">István Ujhelyi (S&amp;D), </span></span>  <span class="italic">írásban. ‒ </span>A Számvevőszék az ügynökség 2014-es pénzügyi évről szóló éves beszámolójáról készített jelentésében megállapította, hogy kellő mértékben megbizonyosodott az Európai Gyógyszerügynökség 2014-es pénzügyi évre vonatkozó éves beszámolójának megbízhatóságáról, valamint arról, hogy az annak alapjául szolgáló ügyletek jogszerűek és szabályszerűek. Szavazatommal támogattam.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1395-0452"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/131507.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Miguel Urbán Crespo (GUE/NGL), </span></span>  <span class="italic">por escrito. ‒ </span>Se ha votado a favor de la aprobación la gestión y del cierre de cuentas al no encontrarse irregularidades reseñables. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1395-0468"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124972.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Ernest Urtasun (Verts/ALE), </span></span>  <span class="italic">por escrito. ‒ </span>He votado a favor de este informe porque creo que la evaluación del Parlamento Europeo sobre la gestión de 2014 de la Agencia Europea de Medicamentos es correcta.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1395-0500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96698.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Viktor Uspaskich (ALDE),</span></span>   <span class="italic">raštu</span><span class="bold">. –</span> Palankiai vertinu tai, jog Audito Rūmai pranešė, kad Agentūros 2014 finansinių metų metinėse finansinėse ataskaitose nurodytos operacijos visais reikšmingais aspektais yra teisėtos ir tvarkingos.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1395-0562"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125032.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Ramón Luis Valcárcel Siso (PPE), </span></span>  <span class="italic">por escrito. ‒ </span>La Corte de Auditores ha señalado que en el año 2014 se han observado menos incidencias relativas a las agencias. Debido a su correcto funcionamiento, la comisión de control presupuestario aprobó por una amplia mayoría la gestión de esta agencia. Por ello considero necesario votar a favor de esta decisión.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1395-0593"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125100.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Miguel Viegas (GUE/NGL), </span></span>  <span class="italic">por escrito. ‒ </span>O Tribunal de Contas, no seu relatório sobre as contas anuais para o exercício de 2014, afirmou ter obtido garantias razoáveis de que as contas anuais da Agência são fiáveis e de que as operações subjacentes são legais e regulares.</p>
<p class="contents">Neste sentido, e não obstante as nossas reservas face ao caráter centralizador e federalista de grande parte destes organismos, não apresentamos nenhuma oposição de princípio a esta quitação.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1395-0609"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/125001.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Harald Vilimsky (ENF), </span></span>  <span class="italic">schriftlich. ‒ </span>Im Bericht werden die Probleme im Haushalt der Agentur detailliert aufgelistet und kritisch dargestellt. Deswegen habe ich dieser Resolution zugestimmt. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1395-0617"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/124825.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Beatrix von Storch (EFDD), </span></span>  <span class="italic">schriftlich. ‒ </span>Den Bericht des Europäischen Parlaments über die Entlastung für die Ausführung des Haushaltsplans der Europäischen Arzneimittel-Agentur für das Haushaltsjahr 2014 habe ich abgelehnt. Ich lehne EU-Agenturen grundsätzlich ab. EU-Agenturen sind nicht nur in den allermeisten Fällen eine Verschwendung von Geld der Steuerzahler, sondern auch eine Überschreitung der Kompetenzen der EU und verletzen das Subsidiaritätsprinzip. Ich will nicht mehr EU, sondern weniger- also auch nicht mehr Agenturen und mehr Geld für die EU, sondern weniger. Aus diesem Grund habe ich gegen diesen Bericht gestimmt.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="2-1395-0750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96933.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Milan Zver (PPE), </span></span>  <span class="italic">pisno. ‒ </span>Glasoval sem za Poročilo o razrešnici glede izvrševanja proračuna Evropske agencije za zdravila za proračunsko leto 2014, ker Računsko sodišče v svojem poročilu o zaključnem računu agencije za leto 2014 ugotavlja, da je v skladu z načeli zakonitosti in pravilnosti ter dobrega finančnega poslovodenja.</p></td><td width="16"> </td></tr></table></td></tr></table><table width="100%" border="0" cellspacing="0" cellpadding="5"><tr class="footerdocwin"><td></td><td align="right"><a target="_blank" href="/legal-notice/en">Legal notice</a> - <a target="_blank" href="/privacy-policy/en">Privacy policy</a></td></tr></table></td></tr></table></body></html>
